| Acronym
|
Trial Name
|
| 3CPO
|
Effect Of Continuous Positive Airway Pressure And Noninvasive Positive Pressure Ventilation In Acute Cardiogenic Pulmonary Oedema
|
| 3T/2R
|
Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel
|
| 4D
|
Deutsche Diabetes Dialysis Study
|
| 4E
|
Efficacy And Safety Of Eplerenone, Enalapril, And Eplerenone/Enalapril Combination Therapy In Patients With Left Ventricular Hypertrophy
|
| 4S
|
Scandinavian Simvastatin Survival Study
|
| 6C trial
|
Cooperative Colorectal Cancer Combination Chemotherapy Clinical
|
| A to Z, Phase A
|
Aggrastat To Zocor
|
| A to Z, Phase Z
|
Evaluation Of Early Versus Delayed Initiation Of Simvastatin In Patients Who Receive Guideline Based Treatment For Acute Coronary Syndrome
|
| A4 Study
|
Catheter Ablation Versus Antiarrhythmic Drugs For Atrial Fibrillation
|
| AAASPS
|
African American Antiplatelet Stroke Prevention Study
|
| AACHEN
|
Angiotensin II Receptor Blocker Candesartan Cilexetil On Intimal Hyperplasia After Coronary Stent Implantation
|
| AASK
|
African American Study Of Kidney Disease And Hypertension
|
| ABACAS
|
Adjunctive Balloon Angioplasty Following Coronary Atherectomy Study
|
| ABC study
|
Association Of Black Cardiologists Study Of Hypertension
|
| ABCD
|
Alternans Before Cardioverter Defibrillator
|
| AbESTT
|
Abciximab Emergent Stroke Treatment Trial
|
| ABOARD
|
Immediate Versus Next Day Catheterization In Non-St Elevation Acute Coronary Syndrome
|
| ABSORB: 6-month and 2-year results
|
A Bioabsorbable Everolimus-Eluting Coronary Stent System For Patients With Single De-Novo Coronary Artery Lesions
|
| ACADEMIC
|
Azithromycin In Coronary Artery Disease: Elimination Of Myocardial Infection With Chlamydia
|
| ACAS
|
Asymptomatic Carotid Atherosclerosis Study
|
| ACC AMI GAP
|
American College Of Cardiology Acute Myocardial Infarction Guidelines Applied To Practice Study
|
| ACCENT
|
A Crohn's Disease Clinical Trial Evaluating Infliximab In A New Long-Term Treatment Regimen
|
| ACCEPT
|
The Accupril Canadian Clinical Evaluation And Patient Teaching Study
|
| ACCESS
|
Acute Candesartan Cilexetil Evaluation In Stroke Survivors
|
| ACCLAIM
|
Advanced Chronic Heart Failure Clinical Assessment Of Immune Modulation Therapy
|
| ACCOMPLISH
|
Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension
|
| ACCORD
|
Action To Control Cardiovascular Risk In Diabetes
|
| ACCT
|
Sex And Age Related Antihypertensive Effects Of Amlodipine
|
| ACCURACY
|
Assessment By Coronary Computed Tomographic Angiography Of Individuals Undergoing Invasive Coronary Angiography
|
| ACE
|
Abciximab-Carbostent Evaluation
|
| ACE
|
Anticoagulation For Cardioversion Using Enoxaparin
|
| ACE (Carotid Endarterectomy)
|
Asa And Carotid Endarterectomy Trial
|
| ACES
|
Azithromycin And Coronary Events Study In Patients With Stable Coronary Disease
|
| ACES
|
Clinical Experience Study
|
| ACIP
|
Asymptomatic Cardiac Ischemia Pilot Study
|
| ACME
|
Angioplasty Compared To Medicine
|
| ACME-2
|
Angioplasty Compared To Medicine - Two-Vessel Disease
|
| A-COMET-I
|
Azimilide—Cardioversion Maintenance Trial–I
|
| A-COMET-II
|
Azimilide—Cardioversion Maintenance Trial–II
|
| ACORN
|
Assessment Of A Cardiac Support Device (Csd) In Patients With Heart Failure
|
| ACRE
|
Appropriateness Of Coronary Revascularization
|
| ACST
|
Asymptomatic Carotid Surgery Trial
|
| ACT
|
Effects Of Physical Activity Counseling In Primary Care: The Activity Counseling Trial
|
| ACT
|
Angioplasty Compliance Trial
|
| ACTION
|
Coronary Disease Trial Investigating Outcome With Nifedipine Gits
|
| ACTION
|
Actinomycin Eluting Stent Improves Outcomes By Reducing Neointimal Hyperplasia
|
| ACTIV in CHF
|
Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure
|
| ACTIVATE
|
Acat Inhibition On The Progression Of Coronary Atherosclerosis
|
| ACTIVE A
|
The Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events
|
| ACTIVE W
|
Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events
|
| ACUITY
|
Acute Catheterization And Urgent Intervention Triage Strategy Trial
|
| ACUITY PCI: 30-day and 1-Year Results
|
Acute Catheterization And Urgent Intervention Triage Strategy Trial - Pci Subgroup: 30-Day And 1-Year Results
|
| ACUITY Timing Trial
|
Acute Catheterization And Urgent Intervention Triage Strategy Timing Trial
|
| ACUTE
|
Assessment Of Cardioversion Using Transesophageal Echocardiography
|
| ACUTE
|
Analysis Of Coronary Ultrasound Thrombolysis Endpoints In Acute Myocardial Infarction
|
| ACUTE II
|
Assessment Of Cardioversion Using Transesophageal Echocardiography
|
| ADAM
|
Aneurysm Detection And Management Veterans Affairs Cooperative Study
|
| ADAM
|
Amsterdam Duration Of Antiretroviral Medication Study
|
| ADAPT
|
Alzheimer's Disease Anti-Inflammatory Prevention Trial
|
| ADCS
|
Alzheimer's Disease Cooperative Study
|
| ADEMEX
|
Adequacy Of Peritoneal Dialysis In Mexico
|
| ADEPT
|
Advanced Elements Of Pacing Trial
|
| ADIOS
|
Antiarrhythmic Drug Improve Outcome Study
|
| ADMIRAL
|
Platelet Glycoprotein IIb/IIia Inhibition With Coronary Stenting For Acute Myocardial Infarction
|
| ADMIRAL
|
Abciximab Before Direct Angioplasty And Stenting In Myocardial Infarction Regarding Acute And Long-Term Followup
|
| ADMIT
|
Arterial Disease Multiple Intervention Trial
|
| ADONIS
|
Aspirin Dose Optimized In Noncardioembolic Ischemic Stroke
|
| ADOPT
|
Atrial Dynamic Overdrive Pacing Trial
|
| ADOPT
|
A Diabetes Outcome Progression Trial
|
| ADOPT-A
|
Atrial Dynamic Overdrive Pacing Trial-A
|
| ADVANCE
|
A Randomized Comparison Of The Value Of Additional Stenting After Optimal Balloon Angioplasty For Long Coronary Lesions
|
| ADVANCE
|
Additive Value Of Tirofiban Administered With The High-Dose Bolus In The Prevention Of Ischemic Complications During High-Risk Coronary Angioplasty
|
| ADVANCE
|
Action In Diabetes And Vascular Disease: Preterax And Diamicron Modified Release Controlled Evaluation
|
| ADVANCE
|
A Dosing Evaluation Of A Vasopressin Antagonist In Chf Patients Undergoing Exercise
|
| ADVENT
|
Assessment Of Diabetes Control And Evaluation Of The Efficacy Of Niaspan Trial
|
| AEGIS
|
Alternative Graft Investigational Study
|
| A-F
|
Vascular Protection In High-Risk Non–St-Elevation Acute Coronary Syndromes: The Angioplasty Balloon-Associated Coronary Debris And The Ez Filterwire
|
| AFASAK
|
Atrial Fibrillation, Aspirin, Antikoagulation
|
| AFASAK-2
|
Second Copenhagen Atrial Fibrillation, Aspirin, And Anticoagulation Study
|
| AFCAPS
|
Air Force Coronary Atherosclerosis Prevention Study
|
| AFCAPS/TEXCAPS
|
Air Force Texas Coronary Atherosclerosis Prevention Study
|
| AF-CHF
|
Atrial Fibrillation And Congestive Heart Failure
|
| AFFIRM
|
Atrial Fibrillation Follow-Up Investigation Of Rhythm Management
|
| AFIB
|
Atrial Fibrillation Investigation With Bidisomide
|
| AFREGS
|
Armed Forces Regression Study
|
| AGENT
|
Angiogenic Gene Therapy
|
| AGENT-2
|
Angiogenic Gene Therapy Trial 2
|
| AGENT-3
|
A Multicenter, Prospective, Randomized Trial Of Intracoronary Administration Of Ad5Fgf-4 In Patients With No Revascularization Options
|
| AGIS
|
Advanced Glaucoma Intervention Study
|
| A-HeFT
|
African-American Heart Failure Trial
|
| AiMI
|
A Prospective, Randomized, Controlled Trial Of Thrombectomy With The Angiojet In Acute Myocardial Infarction
|
| AIMS
|
Apsac Intervention Mortality Study
|
| AIR
|
Aerosolized Iloprost Randomized Placebo-Controlled Study
|
| Air PAMI
|
The Air Primary Angioplasty In Myocardial Infarction Study
|
| AIRCRAFT
|
The Australian Intervention Randomized Control Of Rate In Atrial Fibrillation Trial
|
| AIRE
|
Acute Infarction Ramipril Efficacy Study
|
| AIST-ASH
|
Acute Ischemic Stroke Trial: Oral Aspirin Vs Intravenous Heparin On Stroke Progression
|
| ALBION
|
Assessment Of The Best Loading Dose Of Clopidogrel To Blunt Platelet Activation, Inflammation, And On-Going Necrosis
|
| ALERT
|
Assessment Of Lescol In Renal Transplantation
|
| ALERT
|
Adjunctive Lamictal In Epilepsy And Response To Treatment
|
| ALIVE
|
Azimilide Post-Infarct Survival Evaluation
|
| ALIVE
|
Adenosine Lidocaine Infarct Zone Viability Enhancement
|
| ALIVE (amio vs. lidocaine
|
Amiodarone As Compared With Lidocaine For Shock-Resistant Ventricular Fibrillation
|
| ALKK
|
Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte
|
| ALLAY
|
Aliskiren In Left Ventricular Hypertrophy
|
| ALLHAT
|
Antihypertensive And Lipid-Lowering Treatment To Prevent Heart Attack Trial
|
| ALLIANCE
|
Aggressive Lipid-Lowering Initiation Abates New Cardiac Events
|
| ALOFT
|
Aliskiren Observations Of Heart Failure Treatment
|
| ALPHA
|
T-Wave Alternans In Patients With Heart Failure
|
| ALPHABET
|
Effects Of Beraprost Sodium, An Oral Prostacyclin Analogue, In Patients With Pulmonary Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial
|
| ALTS
|
Ascus/Lsil Triage Study
|
| AMADEUS
|
Comparison Of Idraparinux With Vitamin K Antagonists For Prevention Of Thromboembolism In Patients With Atrial Fibrillation
|
| AMAZE
|
A Multicenter Trial Using-Zestril Versus To Evaluate The Effects On Lowering Blood Pressure
|
| AMEthyst
|
Assessment Of The Medtronic Ave Interceptor Saphenous Vein Graft Filter System
|
| AMIGO
|
Atherectomy And Multilink Stenting Improves Gain In Outcome Trial
|
| AMIGO
|
Ac2993: Diabetes Management For Improving Glucose Outcome
|
| AMIHOT
|
Acute Myocardial Infarction With Hyperoxemic Therapy
|
| AMIHOT II
|
Acute Myocardial Infarction With Hyperoxemic Therapy II
|
| AMIOVIRT
|
Amiodarone Versus Implantable Defibrillator In Patients With Nonischemic Cardiomyopathy And Asymptomatic Nonsustained Ventricular Tachycardia Study
|
| AMISTAD I
|
Acute Myocardial Infarction Study Of Adenosine Trial
|
| AMISTAD II
|
Acute Myocardial Infarction Study Of Adenosine II
|
| AMRO
|
Amsterdam-Rotterdam Trial
|
| ANBP2
|
Australian National Blood Pressure Study Group
|
| ANDROMEDA
|
Increased Mortality After Dronedarone Therapy For Severe Heart Failure
|
| ANTHEM–TIMI-32
|
Anticoagulation With Rnapc2 To Eliminate Mace/Timi 32
|
| ANTIBIO
|
Antibiotic Therapy After An Acute Myocardial Infarction
|
| ANZ-Carvedilol
|
Australia-New Zealand Heart Failure Research Collaborative Group Carvedilol Trial
|
| APAF
|
Ablation For Paroxysmal Atrial Fibrillation (Apaf) Trial
|
| APASS
|
Antiphospholipid Antibody Stroke Study
|
| APC
|
Adenoma Prevention With Celecoxib
|
| APEX AMI
|
Assessment Of Pexelizumab In Acute Myocardial Infarction
|
| APLAUSE
|
Anti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
|
| APOCARD
|
Imaging In Cardiac Transplant Patients
|
| APPRAISE-1
|
Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial
|
| APPROACH
|
Assessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
|
| APRES
|
Angiotensin-Converting Enzyme Inhibition Post Revascularization Study
|
| APRICOT
|
Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
|
| APRICOT-2
|
Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
|
| ARBITER 2
|
Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2
|
| ARCH
|
Amiodarone Reduction In Coronary Heart Trial
|
| ARCHeR
|
For Revascularization Of Carotids In High-Risk Patients
|
| AREDS
|
Age-Related Eye Disease Study
|
| ARG-911
|
Argatroban-911
|
| ARG-915
|
Argatroban-915
|
| ARGAMI-2
|
Argatroban For Acute Myocardial Infarction
|
| ARIC
|
Atherosclerosis Risk In Communities
|
| ARIES 1 and 2
|
Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
|
| ARISE
|
Aggressive Reduction Of Inflammation Stops Events
|
| ARMS
|
Apsac Reocclusion Multicenter Study
|
| ARMYDA
|
Atorvastatin For Reduction Of Myocardial Damage During Angioplasty
|
| ARMYDA-2
|
Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
|
| ARMYDA-3
|
Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
|
| ARMYDA-4
|
Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
|
| ARMYDA-5
|
Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
|
| ARMYDA-ACS
|
Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
|
| ARMYDA-RECAPTURE
|
Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
|
| ARMYDA-RELOAD
|
Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
|
| ARPEGGIO
|
Rimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
|
| ARREST
|
Amiodarone For Resuscitation After Out-Of-Hospital Cardiac Arrest Due To Ventricular Fibrillation
|
| ARREST
|
Angiorad Radiation For Restenosis
|
| ARTIST
|
Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
|
| ARTISTIC
|
Angiorad Radiation Therapy For In-Stent Restenosis Intracoronary
|
| ARTS
|
Arterial Revascularization Therapies Study
|
| ARTS I - Five year follow-up
|
Five Year Clinical Follow-Up Of The Arterial Revascularisation Therapy Study
|
| ARTS-II
|
Arterial Revascularization Therapies Study Part II: Sirolimus-Eluting Stents For The Treatment Of Patients With Multivessel De Novo Coronary Artery Lesions
|
| ASAP
|
Effect Of Aggressive Versus Conventional Lipid Lowering On Atherosclerosis Progression In Familial Hypercholesterolemia
|
| ASAP
|
Azimilide Supraventricular Arrhythmia Program
|
| ASCENT
|
Acs Stent Clinical Equivalence In De Novo Lesions Trial
|
| ASCOT
|
Anglo-Scandinavian Cardiac Outcome Trial
|
| ASCOT - Blood Pressure Arm
|
Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm
|
| ASCOT - Lipid Arm
|
Anglo-Scandinavian Cardiac Outcomes Trial
|
| ASFAST
|
Atherosclerosis And Folic Acid Supplementation Trial
|
| ASIS
|
Angina And Silent Ischemia Study
|
| ASPAC
|
Asian-Pacific Collaboration On Chd Risk Factor Intervention
|
| ASPECT
|
Anticoagulants In Secondary Prevention Of Events In Coronary Thrombosis
|
| ASPECT
|
Asian Paclitaxel-Eluting Stent Clinical Trial
|
| ASPECT-2
|
Aspirin And Coumadin After Acute Coronary Syndromes (The Aspect-2) Study: A Randomised Controlled Trial.
|
| ASPEN
|
Atorvastatin Study For The Prevention Of Endpoints For Patients With Niddm
|
| ASPIRE
|
Arixtra Study In Percutaneous Coronary Intervention: A Randomized Evaluation
|
| ASSENT 3
|
The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Randomized Trial In Acute Mi
|
| ASSENT 3 PLUS
|
Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen-3
|
| ASSENT-1
|
Assessment Of The Safety and Efficacy Of A New Thrombolytic: Tnk-Tpa
|
| ASSENT-2
|
Assessment Of The Safety And Efficacy Of A New Thrombolytic: Tnk-Tpa-2
|
| ASSENT-4 PCI
|
Assessment Of The Safety And Efficacy Of A New Treatment Strategy For Acute Myocardial Infarction
|
| ASSERT
|
Aortic Stentless Versus Stented Valve Assessed By Echocardiography Randomized Trial
|
| ASSET
|
Anglo-Scandinavian Study Of Early Thrombolysis
|
| ASSIST
|
Assessment Of Implementation Strategies
|
| ASSIST
|
A Stop Smoking In Schools Trial
|
| ASSURE
|
Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit Of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter Defibrillator Implantations
|
| ASTAMI
|
Astami
|
| ASTEROID
|
A Study To Evaluate The Effect Of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden
|
| ASTIS
|
Autologous Stem Cell Transplantation International Scleroderma Trial
|
| ASTRAL
|
Angioplasty And Stenting For Renal Artery Lesions
|
| ASTRID
|
Atrial Sensing Trial To Prevent Inappropriate Detections
|
| ASTRONAUT
|
Acid Suppression Trial: Ranitidine Zantac Versus Omeprazole
|
| AT LAST
|
Antiretroviral Trial Looking At Sex And Treatment
|
| ATAC
|
Arimidex (Anastrozole), Tamoxifen And Combination Therapy
|
| ATBAT
|
Anticoagulant Therapy With Bivalirudin To Assist In Pci 1St Inning Trial (Pci In Hit/Hitts)
|
| ATBC
|
Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study
|
| ATHENA
|
Effect Of Dronedarone On Cardiovascular Outcomes In High-Risk Patients With Atrial Fibrillation Or Atrial Flutter
|
| ATHEROMA
|
Atorvastatin Therapy: Effects Of Reduction Of Macrophage Activity
|
| ATICH
|
Antifibrinolytic Therapy In Acute Intracerebral Hemorrhage
|
| ATLANTIC
|
Angina Treatments - - Lasers And Normal Therapies In Comparison
|
| ATLANTIS
|
Alteplase Thrombolysis For Acute Noninterventional Therapy In Ischemic Stroke
|
| ATLAS
|
Assessment Of Treatment With Lisinopril And Survival
|
| ATLAS
|
Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts Assessment Of Treatment With Lisinopril And Survival
|
| ATLAS - SVG
|
Acolysis During Treatment Of Lesions Affecting Saphenous Vein Bypass Grafts
|
| ATLAST
|
Antiplatelet Therapy Alone Versus Lovenox Plus Antiplatelet Therapy In Patients At Increased Risk Of Stent Thrombosis
|
| ATLAS-TIMI 46
|
Anti-Xa Therapy To Lower Cardiovascular Events In Addition To Aspirin With Or Without Thienopyridine In Subjects With Acute Coronary Syndromes–Thrombolysis In Myocardial Infarction 46
|
| AtoZ
|
Aggrastat To Zocor Study
|
| ATRAMI
|
Baroreflex Sensitivity And Heart-Rate Variability In Prediction Of Total Cardiac Mortality After Myocardial Infarction. Atrami (Autonomic Tone And Reflexes After Myocardial Infarction) Investigators.
|
| ATRIA
|
The Anticoagulation And Risk Factors In Atrial Fibrillation Study
|
| ATRIA
|
Anticoagulation And Risk Factors In Atrial Fibrillation
|
| Atrial Arrhythmia Conversion Trial
|
Vernakalant Hydrochloride For Rapid Conversion Of Atrial Fibrillation
|
| ATS
|
Amblyopia Treatment Study
|
| ATTACH
|
Anti-Tnf Therapy Against Congestive Heart Failure Trial
|
| ATTEST
|
Atrial Therapy Efficacy And Safety Trial
|
| ATTRACT
|
Anti-Tnf Trial In Rheumatoid Arthritis With Ca2 Treatment
|
| AURORA
|
A Study To Evaluate The Use Of Rosuvastatin In Subjects On Regular Hemodialysis: An Assessment Of Survival And Cardiovascular Events
|
| AVASIS
|
Aspirin Versus Anticoagulants In Symptomatic Intracranial Stenosis
|
| AVERT
|
Atorvastatin Versus Revascularization Treatments
|
| AVERT
|
Artificial Valve Endocarditis Reduction Trial
|
| AVID
|
Antiarrhythmics Versus Implantable Defibrillators
|
| AVID
|
Angiography Versus Intravascular Ultrasound-Directed Stent Placement
|
| AVID Electrical Storm Substudy
|
Electrical Storm Presages Nonsudden Death. The Antiarrhythmics Vs. Implantable Defibrillators (Avid) Trial
|
| AVOID
|
Aliskiren In The Evaluation Of Proteinuria In Diabetes
|
| AWESOME
|
Angina With Extremely Serious Operative Mortality Evaluation
|
| AZACS
|
Azithromycin In Acute Coronary Syndrome
|
| BAATAF
|
Boston Area Anticoagulation Trial For Atrial Fibrillation
|
| BACH
|
Bach
|
| BARI
|
Bypass Angioplasty Revascularization Investigation
|
| BARI 2D
|
Bypass Angioplasty Revascularization Investigation In Type 2 Diabetics
|
| BARS
|
Beaumont Alcohol Restenosis Study
|
| BASC
|
Blood Pressure In Acute Stroke Collaboration
|
| BASEL
|
Brain Natriuretic Peptide For Acute Shortness Of Breath Evaluation: A Randomized Comparison
|
| BASIS
|
Basel Antiarrhythmic Study Of Infarct Survival
|
| BASKET
|
Basel Stent Cost-Effectiveness Trial
|
| BASKET LATE
|
Late Clinical Events Related To Late Stent Thrombosis After Stopping Clopidogrel
|
| BAT
|
Bivalirudin Angioplasty Study
|
| BATMAN
|
Biodivysio 'Bat'Imastat Sv Stent Versus Balloon Angioplasty For The Reduction Of Restenosis In Small Coronary Arteries
|
| BBC ONE
|
British Bifurcation Coronary Study: Old, New, And Evolving Strategies
|
| BBS—Cognitive Study
|
Best Bypass Surgery—Cognitive Study
|
| BCAPS
|
Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study
|
| BCPT
|
Breast Cancer Prevention Trial
|
| BEACH
|
Boston Scientific Epi: A Carotid Stenting Trial For High-Risk Surgical Patients
|
| BEAT
|
Bucindolol Evaluation In Acute Myocardial Infarction Trial
|
| BEAUTIFUL
|
Morbidity-Mortality Evaluation Of The If Inhibitor Ivabradine In Patients With Coronary Disease And Left-Ventricular Dysfunction
|
| BECAIT
|
Bezafibrate Coronary Atherosclerosis Intervention Trial
|
| BECAIT
|
Bezafibrate Coronary Atherosclerosis Intervention Trial
|
| BELLES
|
Beyond Endorsed Lipid Lowering With Ebt Scanning
|
| BENEDICT
|
Bergamo Nephrologic Diabetes Complications Trial
|
| BENEFiT
|
Bosentan Effects In Inoperable Forms Of Chronic Thromboembolic Pulmonary Hypertension
|
| BENEFIT
|
Betaferon (Betaseron In U.S.) In Newly Emerging Ms For Initial Treatment Information
|
| BENESTENT I
|
Belgian-Netherlands Stent Study (I)
|
| BENESTENT II
|
Belgian-Netherlands Stent Study II (Pilot)
|
| BERT
|
Beta Energy Restenosis Trial - 1
|
| BESMART
|
Bestent In Small Arteries Trial
|
| BESSAMI
|
Berlin Stent Study In Acute Myocardial Infarction
|
| BEST
|
Beta Blocker Evaluation Of Survival Trial
|
| BEST
|
Balloon Equivalent To Stent Trial
|
| BEST-ICD
|
Beta-Blocker Evaluation Of Survival Trial Plus Icd
|
| BETA WRIST
|
Washington Radiation For In-Stent Restenosis Trial
|
| BETACATH
|
Clinical And Angiographic Outcomes After Use Of Sr-90 Beta Radiation For The Treatment Of De Novo And Restenotic Coronary Lesions
|
| BETTER
|
Beta Radiation Trial To Eliminate Restenosis
|
| BHACAS
|
Early And Midterm Outcome After Off-Pump And On-Pump Surgery In Beating Heart Against Cardioplegic Arrest Studies (Bhacas 1 And 2): A Pooled Analysis Of Two Randomised Controlled Trials.
|
| BHAT
|
Beta Blocker Heart Attack Trial
|
| BiCard
|
Biphasic Vs. Monophasic Shock Waveform For Conversion Of Atrial Fibrillation. The Results Of An International Randomized, Double-Blind Multicenter Trial
|
| BICC
|
Beta-Interferon In Chronic Viral Cardiomyopathy
|
| BIP
|
Bezafibrate Infarction Prevention Study
|
| BIRD
|
Bolus Versus Infusion In Rescupase (Saruplase) Development
|
| BLIND-DATE
|
Blinded Withdrawal Of Deprenyl In The Datatop Extension Trial
|
| BLOSS
|
Beta Blocker Length Of Stay Study
|
| BNP
|
Breathing Not Properly
|
| BOAT
|
Balloon Angioplasty Versus Optimal Atherectomy Trial
|
| Bogalusa
|
Bogalusa Heart Study
|
| BOOST
|
Bone Marrow Transfer To Enhance St-Elevation Infarct Regeneration
|
| BPAV
|
Balloon Prophylaxis Of Aneurysmal Vasospasm
|
| BRAINS
|
Bayer Randomized Acute Ischemia Neuroprotectant Study
|
| BRAVE
|
Bavarian Reperfusion Alternatives Evaluation
|
| BRAVE-2
|
Beyond 12 Hours Reperfusion Alternative Evaluation Trial
|
| BRAVE-3
|
Value Of Abciximab In Patients With Ami Undergoing Pci After High Loading Dose Of Clopidogrel Pretreatment
|
| BRAVO
|
Blockade Of The Glycoprotein IIb/IIia Receptor To Avoid Vascular Occlusion
|
| BRAVO
|
Beta Radiation For Treatment Of Arteriovenous Graft Outflow Sponsor:
|
| BREATHE-1
|
Bosentan (Tracleer): Randomized Trial Of Endothelin Receptor Antagonist Therapy For Pulmonary Hypertension
|
| BRIDGE
|
Beta-Radiation Investigation With Direct Stenting And Galileo In Europe
|
| BRIE
|
Beta Radiation In Europe
|
| BRIEF-PCI
|
Brief Infusion Of Eptifibatide Following Percutaneous Coronary Intervention
|
| BRILLIANT
|
Batimastat (Bb-94) Antirestenosis Trial Utilizing The Biodivysio Local Drug Delivery Pc Stent
|
| BRITE
|
Beta Radiation To Reduce In-Stent Restenosis
|
| BRITE II
|
Beta Radiation To Reduce In-Stent Restenosis II
|
| BRITE-SVG
|
Beta Radiation To Reduce In-Stent Restenosis In Saphenous Vein Grafts
|
| CABERNET
|
A Prospective Registry Of Carotid Stenting With The Nexstent And Distal Protection With The Filterwire Ex In High Risk Patients
|
| CABERNET
|
Carotid Artery Revascularization Using The Boston Scientific Epi Filterwire Ex And The Endotex Nexstent
|
| CABG PATCH
|
The Coronary Artery Bypass Graft Patch Trial
|
| CABG Patch Cardioplegia Substudy
|
Does Cardioplegia Type Affect Outcome And Survival In Patients With Advanced Left Ventricular Dysfunction? Results From The Cabg Patch Tria
|
| CABRI
|
Coronary Angioplasty Versus Bypass Revascularization Investigation
|
| CACAF
|
Catheter Ablation For The Cure Of Atrial Fibrillation Study
|
| CACHET
|
Comparison Of Abciximab Complications With Hirulog (Angiomax As Of 1999) Ischemic Events Trial
|
| CACTUS
|
Coronary Bifurcations: Application Of The Crushing Technique Using Sirolimus-Eluting Stents
|
| CADILLAC
|
Controlled Abciximab (Reopro) And Device Investigation To Lower Late Angioplasty Complications
|
| CAESAR
|
Canada, Australia, Europe, South Africa Aids Study
|
| CAFA
|
Canadian Atrial Fibrillation Anticoagulation Study
|
| CAFE
|
Conduit Artery Function Evaluation
|
| CALM
|
Candesartan And Lisinopril Microalbuminuria Study
|
| CALM-PD
|
Comparison Of The Agonist Pramipexole Vs. Levodopa On Motor Complications In Parkinson Disease
|
| CALYPSO
|
Cylexin As An Adjunct To Lytic Therapy To Prevent Superoxide Reflow Injury
|
| CAMELOT
|
Comparison Of Amlodipine Versus Enalapril (Lipitor) To Limit Occurrences Of Thrombosis
|
| CAMEO
|
Cerebral Aneurysm Multicenter European
|
| CAMIAT
|
Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (Pilot)
|
| CANDLE
|
Candesartan Versus Losartan Efficacy Comparison
|
| Cangrelor during PCI
|
Cangrelor During Percutaneous Coronary Intervention
|
| CANPAP
|
Continuous Positive Airway Pressure For Heart Failure Patients With Central Sleep Apnea
|
| CAPARES
|
Coronary Angioplasty Amlodipine Restenosis Study
|
| CAPE II
|
Medical Treatment Of Myocardial Ischemia In Coronary Artery Disease: Effect Of Drug Regime And Irregular Dosing In The Cape II Trial
|
| CAPITAL AMI
|
Combined Angioplasty And Pharmacological Intervention Versus Thrombolytics Alone In Acute Myocardial Infarction
|
| CAPPP
|
Captopril Prevention Project
|
| CAPRICORN
|
Carvedilol Post Infarct Survival Control in Left Ventricular Dysfunction Study
|
| CAPRIE
|
Clopidogrel Versus Aspirin In Patients At Risk Of Ischemic Events
|
| CAPS
|
The Cardiac Arrhythmic Pilot Study
|
| CAPT
|
Complications Of Amd (Age-Related Macular Degeneration) Prevention Trial
|
| CAPTEN
|
Captopril After Thrombolysis Trial
|
| CAPTIM
|
Comparison Of Angioplasty And Prehospital Thrombolysis In Acute Myocardial Infarction
|
| CAPTIN
|
Captopril Plus Tissue Plasminogen Activator Following Acute Myocardial Infarction
|
| CAPTIVATE
|
Carotid Atherosclerosis Progression Trial Investigating Vascular Acat Inhibition Treatment Effects
|
| CAPTIVE
|
A Prospective, Randomized, Controlled Trial Of Distal Protection With The Third Generation Mednova Emboshield Compared To The Guardwire Or Filterwire
|
| CAPTURE
|
Chimeric 7E3 Antiplatelet Therapy In Unstable Angina Refractory To Standard Treatment
|
| CAPTURE Registry
|
Carotid Acculink/Accunet Post-Approval Trial To Uncover Unanticipated Or Rare Events Registry
|
| CARAT
|
Coronary Angioplasty And Rotational Atherectomy Trial
|
| CARDIA
|
Coronary Artery Risk Development In Young Adults
|
| CARDia
|
Coronary Artery Revascularization In Diabetes Trial
|
| CARDINAL
|
Complement And Reduction Of Infarct Size After Angioplasty Or Lytics
|
| CARDS
|
Collaborative Atorvastatin (Lipitor) And Diabetes Study
|
| CARE
|
Cardiac Angiography In Renally Impaired Patients
|
| CARE
|
Cholesterol And Recurrent Events
|
| CARE
|
Calcium Antagonist In Reperfusion Cholesterol And Recurrent Events Carvedilol Atherectomy Restenosis
|
| CARE-HD
|
Coenzyme Q10 And Remacemide: Evaluation In Huntington Disease
|
| CARE-HF
|
Cardiac Resynchronization - Heart Failure European Complement To U.S./Canada Miracle Study
|
| CARESS
|
Clopidogrel And Aspirin For Reduction Of Emboli In Symptomatic Carotid Stenosis
|
| CARESS-in-AMI: 30-Day and 1-Year Results
|
Combined Abciximab Reteplase Stent Study In Acute Myocardial Infarction: 30-Day and 1-Year Results
|
| CARET
|
The Beta Carotene And Retinol Efficacy Trial
|
| CARIBE
|
Carvedilol Insuficiencia Cardiaca (Heart Failure) Beta-Receptor
|
| CARISA
|
Combination Assessment Of Ranolazine In Stable Angina
|
| CARMEN
|
The Carvedilol And Ace-Inhibitor Remodeling Mild Heart Failure Evaluation Trial
|
| CARMEN
|
Carvedilol Ace Inhibitors Remodelling Mild Heart Failure Evaluation
|
| CARP
|
Coronary Artery Revascularization Prophylaxis
|
| CARS
|
Coumadin Aspirin Reinfarction Study
|
| CART
|
Canadian Antioxidant Restenosis Trial
|
| CARVEDILOL
|
The Effects Of Carvedilol On Morbidity And Mortality In Patients With Chronic Heart Failure
|
| CASCADE
|
Cardiac Arrest In Seattle: Conventional Versus Amiodarone Drug Evaluation Study
|
| CASES
|
Canadian Activase For Stroke Effectiveness Study
|
| CASH
|
Cardiac Arrest Study-Hamburg
|
| CASIS
|
Canadian Amlodipine/Atenolol In Silent Ischemia Study
|
| CASS
|
Coronary Artery Surgery Study
|
| CAST
|
Cardiac Arrhythmia Suppression Trial
|
| CASTEMI
|
Calderet In St Elevation Myocardial Infarction
|
| CAST-II
|
The Cardiac Arrhythmia Suppression Trial II
|
| CASTLE
|
Candesartan Amlodipine Study Of Tolerability And Efficacy
|
| CAT
|
Cardiomyopathy Trial
|
| CAT
|
Chinese Ace Inhibitor In Acute Myocardial Infarction Trial Cardiomyopathy Trial
|
| CATAPULT
|
Cisplatin And Tirapazamine In Subjects With Advanced Previously Untreated Non–Small Cell Lung Tumors
|
| Cathedia Study
|
Femoral Vs. Jugular Venous Catheterization And Risk Of Nosocomial Events In Adults Requiring Acute Renal Replacement Therapy
|
| CATIE
|
Clinical Antipsychotic Trials Of Intervention Effectiveness
|
| CATS
|
Canadian American Ticlopidine Study
|
| CATS
|
Captopril And Thrombolysis Study
|
| CAVATAS
|
Endovascular Versus Surgical Treatment In Patients With Carotid Stenosis In The Carotid And Vertebral Artery Transluminal Angioplasty Study (Cavatas)
|
| CAVEAT I
|
Coronary Angioplasty Versus Excisional Atherectomy Trial I
|
| CAVEAT II
|
Coronary Angioplasty Versus Excisional Atherectomy Trial II
|
| CBT-CD
|
Cognitive Behavior Therapy For The Chronic Depressions
|
| CCAT
|
Canadian Coronary Atherectomy Trial
|
| CCP
|
The Cooperative Cardiovascular Project
|
| CCS-1
|
Chinese Cardiac Study
|
| CDP
|
Coronary Drug Project
|
| CEDARS
|
Comprehensive Evaluation Of Defibrillators And Resuscitative Shock
|
| CELL
|
Cost Effectiveness Of Lipid Lowering Study
|
| CEOS
|
Congenital Esotropia Observational Study
|
| CHAMP
|
Combination Hemotherapy And Mortality Prevention (Champ) Study
|
| CHAMP
|
Children's Hiv And Aids Model Program
|
| CHAMPIONS
|
Controlled High-Risk Subjects Avonex Ms Prevention In Ongoing Neurologic Surveillance
|
| CHAMPS
|
Controlled High-Risk Subjects Avonex Ms Prevention Study
|
| CHAOS
|
Cambridge Heart Antioxidant Study
|
| CHARISMA
|
Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance
|
| CHARM
|
Candesartan Cilexitil (Atacand) In Heart Failure Assessment Of Reduction Mortality And Morbidity
|
| CHARM Added Trial
|
Candesartan In Heart Failure—Added Trial
|
| CHARM Alternative Trial
|
Candesartan In Heart Failure—Alternative Trial
|
| CHARM Overall Programme Results
|
Candesartan In Heart Failure—Assessment Of Reduction In Mortality And Morbidity
|
| CHARM Preserved Trial
|
Candesartan In Heart Failure—Preserved Trial
|
| CHEESE
|
Comparative Trial Of Hiv-Infected Patients Evaluating Efficacy And Safety Of Saquinavir-Enhanced Oral Formulation And Indinavir Given As Part Of A Triple Drug Therapy
|
| CHF-STAT
|
Congestive Heart Failure Survival Trial Of Antiarrhythmic Therapy
|
| CHICAGO
|
Carotid Intima-Media Thickness In Atherosclerosis Using Pioglitazone
|
| CHRISTMAS
|
Carvedilol Hibernating Reversible Ischaemia Trial
|
| CHS
|
Cardiovascular Health Study
CHS
Charleston Heart Study
CHS
Community Health Study
CHS
Congenital Heart Surgeons Society Study
CHS
Coronary Heart Study
|
| CIAO
|
Coronary Interventions Antiplatelet-Based Only
|
| CIBIS
|
Cardiac Insufficiency Bisoprolol Study
|
| CIBIS II
|
The Cardiac Insufficiency Bisoprolol Study II
|
| CIBIS III
|
The Cardiac Insufficiency Bisoprolol Study III
|
| CIDS
|
Canadian Implantable Defibrillator Study
|
| CIGTS
|
Collaborative Initial Glaucoma Treatment Study
|
| CLARIDI
|
Cholesterol Lowering And Arrhythmias Recurrences After Internal Defibrillator Implantation
|
| CLARITY-TIMI 28
|
Clopidogrel As Adjunctive Reperfusion Therapy
|
| CLAS I AND II
|
Cholesterol Lowering Atherosclerosis Study (I And II)
|
| CLASS
|
Celecoxib (Celebrex) Long-Term Arthritis Safety Study
|
| CLASSICS
|
Clopidogrel (Plavix) Aspirin Stent International Cooperative Study
|
| CLASS-IHT
|
Clomethiazole Acute Stroke Study In Ischemic, Hemorrhagic, And Tpa Treated Stroke
|
| CLEAR PLATELETS
|
Clopidogrel Loading With Eptifibatide To Arrest The Reactivity Of Platelets Study
|
| CLEAR PLATELETS-2
|
Clopidogrel With Eptifibatide To Arrest The Reactivity Of Platelets-2
|
| CLEERE
|
Collaborative Longitudinal Evaluation Of Ethnicity And Refractive Error
|
| COACH
|
Coordinating Study Evaluating Outcomes Of Advising And Counseling In Heart Failure
|
| COAST
|
Heparin-Coated Stents In Small Coronary Arteries
|
| COBALT
|
Continuous Infusion Versus Double-Bolus Administration Of Alteplase
|
| COCAD
|
Cognitive Outcomes In Coronary Artery Disease
|
| COLA
|
Carvedilol Open Label Assessment
|
| COLUMBUS
|
Low Molecular Weight Heparin In The Treatment Of Patients With Venous Thromboembolism
|
| COMBINE
|
Combining Medications And Behavorial Interventions
|
| COMET
|
Carvedilol Or Metoprolol European Trial
|
| COMMA
|
Compliment Inhibition In Myocardial Infarction Treated With Percutaneous Transluminal Coronary Angioplasty (Evaluation Of Iv Dosing Regimens Of H5G1.1-Scfv)
|
| COMMIT/CCS-2 – Clopidogrel
|
Randomized, Placebo-Controlled Trial Of Adding Clopidogrel To Aspirin In 46,000 Acute Myocardial Infarction Patients
|
| COMMIT/CCS-2 – Metoprolol
|
Randomized, Placebo-Controlled Trial Of Early Metoprolol In 46,000 Acute Myocardial Infarction Patients
|
| COMPANION
|
Comparison Of Medical Therapy, Pacing And Defibrillation In Chronic Heart Failure
|
| Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenosis
|
Randomized Clinical Trial Investigators. Randomized Comparison Of Gr-II Stent And Palmaz-Schatz Stent For Elective Treatment Of Coronary Stenosis
|
| Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus
|
A Comparison Of Ibuprofen And Indomethacin For Closure Of Patent Ductus Arteriosus
|
| COMPASS
|
Comparison Trial Of Saruplase And Streptokinase
|
| COMPASS-HF
|
Chronicle Offers Management To Patients With Advanced Signs And Symptoms Of Heart Failure
|
| COMPLY
|
Compliment Inhibition In Myocardial Infarction Treated With Thrombolytics (Evaluation Of Iv Dosing Regimens Of H5G1.1-Scfv) Sponsors
|
| COMS
|
Collaborative Ocular Melanoma Study
|
| CONSENSUS
|
The Effects Of Enalapril On Mortality In Severe Congestive Heart Failure
|
| CONSENSUS II
|
The Effects Of The Early Administration Of Enalapril On Mortality In Patients With Acute Myocardial Infarction: Results Of The Cooperative New Scandin-2
|
| CONVERTIBLE
|
Conventional Stenting Versus Direct Stenting In (Un)Stable Angina Pectoris
|
| CONVINCE
|
Controlled Onset Verapamil Investigation Of Cardiovascular Endpoints Trial
|
| COOL
|
Cardiovascular Thrombolytic To Open Occluded Lines
|
| COOL AID
|
Cooling For Acute Ischemic Brain Damage
|
| COOL MI
|
Cooling As An Adjunctive Therapy To Percutaneous Intervention In Patients With Acute Myocardial Infarction
|
| COOLRCN
|
Cooling To Prevent Radiocontrast Nephropathy
|
| COPERNICUS
|
Effect Of Carvedilol On Survival In Severe Chronic Heart Failure
|
| COPPA
|
Clinical Outcomes From The Prevention Of Postoperative Arrhythmia
|
| CORE
|
International Variation In Invasive Procedures And Outcomes In Acute Myocardial Infarction
|
| CORE
|
Continuing Outcomes Relevant To Evista
|
| CORONA
|
Controlled Rosuvastatin Multinational Trial In Heart Failure
|
| CORSICA
|
Chronic Occlusion Revascularization With Stent Implantation Versus Coronary Angioplasty
|
| COSS
|
Carotid Occlusion Surgery Study
|
| COURAGE
|
Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation
|
| COURT
|
Contrast Utilization In High Risk Patients Undergoing Ptca
|
| C-PORT
|
Atlantic Cardiovascular Patient Outcomes Research Team Trial
|
| CPVA for Chronic Atrial Fibrillation
|
Circumferential Pulmonary Vein Ablation For Chronic Atrial Fibrillation
|
| CQI in CABG
|
Continuous Quality Improvement In Coranary Artery Bypass Graft
|
| CRASH
|
Corticosteroid Randomization After Significant Head Injury
|
| CREATE
|
Canadian Cardiac Randomized Evaluation Of Antidepressant And Psychotherapy Efficacy
|
| CREATE ELCA - Reviparin
|
Low Molecular Weight Heparin (Reviparin) In Preventing Mortality, Reinfarction, And Strokes In Over 15,500 Patients With St Elevation Acute Myocardial Infarction
|
| CREATE-ECLA - GIK
|
Impact Of Glucose-Insulin-Potassium On Mortality And Morbidity In Over 20,000 Patients With Acute Myocardial Infarction: The Create-Ecla International Trial
|
| CREDO
|
Clopidogrel For Reduction Of Events During Observation
|
| CREST
|
Cilostazol For Restenosis
|
| CREST
|
Carotid Revascularization Endarterectomy Vs Stenting Trial
|
| CRIS
|
A Controlled Trial Of Verapamil In Patients After Acute Myocardial Infarction: Results Of The Calcium, Antagonist Reinfarction Italian Study
|
| CRUISE
|
Can Routine Ultrasound Influence Stent Expansion
|
| C-SIRIUS
|
Canadian Sirolimus-Eluting Stent In Coronary Lesions
|
| CSSS
|
China Salt Substitute Study
|
| CTAF
|
Canadian Trial Of Atrial Fibrillation
|
| CTOPP
|
Canadian Trial Of Physiologic Pacing
|
| CUBA
|
Cutting Balloon Versus Conventional Angioplasty Study
|
| CURE
|
The Clopidogrel In Unstable Angina To Prevent Recurrent Events Trial Investigators: Effects Of Clopidogrel In Addition To Aspirin In Patients With Acute Coronary Syndromes Without St-Segment Elevation
|
| CURE
|
Clopidogrel In Unstable Angina To Prevent Recurrent Ischemic Events
|
| DAIS
|
Diabetes Atherosclerosis Intervention Study
|
| DAISY
|
Diabetes Autoimmunity Study In The Young
|
| DANAMI
|
Danish Myocardial Infarction Trial
|
| DANAMI-2
|
Danish Trial In Acute Myocardial Infarction-2
|
| DANTE
|
Diabetes Abciximab Stent Evaluation
|
| DAPPAF
|
Dual Site Atrial Pacing To Prevent Atrial Fibrillation
|
| DART
|
Dilation Versus Ablation Revascularization Trial
|
| DASH
|
Dietary Approaches To Stop Hypertension
|
| DATATOP
|
Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism
|
| DAVID
|
Dual-Chamber And Vvi Implantable Defibrillator
|
| DAVID – (Picotamide vs. Aspirin)
|
Drug Evaluation In Atherosclerotic Vascular Disease In Diabetics
|
| DAVID II
|
Dual Chamber And Vvi Implantable Defibrillator II
|
| DAVIT II
|
Danish Study Group On Verapamil In Mi
|
| DCCT
|
Diabetes Control And Complications Trial
|
| DEAR-MI
|
Dethrombosis To Enhance Acute Reperfusion In Myocardial Infarction
|
| DEBATE
|
Doppler Endpoints Balloon Angioplasty Trial Europe
|
| DEBATE II
|
Doppler Endpoints Balloon Angioplasty Trial Europe-2
|
| DEBUT
|
Defibrillator Versus Beta-Blockers For Unexplained Death In Thailand
|
| DECLARE-DIABETES
|
Drug-Eluting Stenting Followed By Cilostazol Treatment Reduces Late Restenosis In Patients With Diabetes Mellitus
|
| DECOPI
|
Randomized Trial Of Occluded Artery Angioplasty After Acute Myocardial Infarction
|
| DECOPI
|
La Desobstruction Coronaire En Post-Infarctus
|
| DECREASE III
|
Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo III
|
| DECREASE-V
|
Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-V
|
| DEDICATION: Distal Protection Study
|
Drug Elution And Distal Protection In St-Elevation Myocardial Infarction
|
| DEDICATION: Stent Study
|
Drug Elution And Distal Protection In Acute Myocardial Infarction
|
| DEFER
|
Deferral Versus Performance Of Ptca In Patients Without Documented Ischemia
|
| DEFINITE
|
Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation
|
| DEFUSE
|
Diffusion-Weighted Imaging Evaluation For Understanding Stroke Evaluation
|
| DELTA MI
|
Direct Inhibition Of Δ-Protein Kinase C Enzyme To Limit Total Infarct Size In Acute Mi
|
| DES-DIABETES
|
A Randomized Comparison Of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation In Patients With Diabetes Mellitus
|
| DESTINI-CFR
|
Doppler Endpoints Stenting International Investigation - Coronary Flow Reserve
|
| DETAIL
|
Diabetics Exposed To Telmisartan And Enalapril
|
| DIABETES
|
A Prospective, Randomized, Controlled Trial Of The Polymer-Based, Sirolimus-Eluting Stent Versus A Bare Metal Stent In Patients With Diabetes Mellitus
|
| DIACOR
|
Diabetes And Combined Lipid Therapy Regimen
|
| DIAD
|
Detection Of Ischemia In Asymptomatic Diabetics
|
| DIADS
|
Depression In Alzheimer Disease Study
|
| DIAGNOSIS
|
Diffusion-Weighted Imaging Assessment Of The Genuine Need For Other Studies In Ischemic Stroke
|
| DIAL
|
Randomized Trial Of Telephone Intervention In Chronic Heart Failure
|
| DIAMOND
|
Danish Investigations Of Arrhythmia And Mortality On Dofetilide
|
| DIAMOND
|
Distensibility Improvement With Alt-711 Remodeling In Diastolic Heart Failure Sponsor
|
| DIAMOND CHF
|
Danish Investigators Of Arrhythmia And Mortality On Dofetilde Congestive Heart Failure
|
| DIDI
|
Diltiazem In Dilated Cardiomyopathy
|
| DIG
|
Digoxin Investigation Group
|
| DIG Enalapril
|
Enalapril Versus Digoxin In Patients With Congestive Heart Failure: A Multicenter Study (Canadian Enalapril Versus Digoxin Study Group)
|
| DIGAMI
|
Diabetes Mellitus Insulin-Glucose Infusion In Acute Myocardial Infarction
|
| DIMT
|
Double-Blind Placebo-Controlled Study Of Ibopamine And Digoxin In Patients With Mild To Moderate Heart Failure: Results Of The Dutch Ibopamine Multic
|
| DINAMIT
|
Defibrillation In Acute Myocardial Infarction Trial
|
| DIPOM
|
Diabetic Postoperative Mortality And Morbidity Trial
|
| DIRECT
|
Direct Stenting Using The Sirolimus-Eluting Stent
|
| DIRECT
|
Direct Myocardial Revascularization In Regeneration Of Endocardial Channels Trial
|
| DIRECT
|
Diabetic Retinopathy Candesartan Trial Candesartan Cilexetil (Atacand)
|
| DIRECTOR
|
Direct Stenting Study With Orbus R Stent
|
| DISC
|
Disability In Strategies For Care
|
| DISCO
|
Direct Coronary Stenting Versus Stenting With Balloon Predilation: Immediate And Follow-Up Results
|
| DISTINCT
|
Biodivysio Stent In Controlled Trial
|
| DMIST
|
Digital Mammographic Imaging Screening Trial
|
| DPP
|
Diabetes Prevention Program Trial
|
| DPT-1
|
Diabetes Prevention Trial - Type 1
|
| DREAM
|
Diabetes Reduction Approaches With Ramipril And Rosiglitazone Medications
|
| DREAM - Ramipril
|
Diabetes Reduction Assessment With Ramipril And Rosiglitazone Medication
|
| DREAM - Rosiglitazone
|
Diabetes Reduction Assessment With Ramipril And Rosiglitazone Medication
|
| DUCCS-1
|
Duke University Clinical Cardiology Study - 1
|
| DUCCS-2
|
Duke University Clinical Cardiology Study - 2
|
| DYSBOT
|
Dysport And Botox Study
|
| EAFT
|
European Atrial Fibrillation Trial
|
| EAGAR
|
Estrogen And Graft Atherosclerosis Research Trial
|
| EARLY
|
Eptifibatide For Acute Coronary Syndromes—Rapid Versus Late Administration For Therapeutic Yield
|
| EARLY
|
Endothelin Antagonist Trial In Mildly Symptomatic Pulmonary Arterial Hypertension Patient
|
| EARLY ACS
|
Early Glycoprotein IIb/IIia Inhibition In Non–St-Segment Elevation Acute Coronary Syndromes
|
| EARS
|
European Atherosclerosis Research Study
|
| EARTH
|
Endothelin Receptor Antagonist Trial In Heart Failure
|
| EASE
|
Ezetimibe Add-On To Statin Therapy For Effectiveness Trial
|
| EAST
|
Emory Angioplasty Vs Surgery Trial
|
| EASTER
|
Estrogen And Stents To Eliminate Restenosis
|
| EASY
|
Early Discharge After Transradial Stenting Of Coronary Arteries
|
| EASYAS
|
Eastbourne Syncope Assessment Study
|
| ECASS III
|
European Cooperative Acute Stroke Study III
|
| ECCE
|
Effects Of Captopril On Cardiopulmonary Exercise Parameters (Ecce)
|
| ECCO 2000
|
Effects Of Citicoline (Ceraxon) On Clinical Outcome - 2000 Mg
|
| ECHO in PPH
|
Echocardiographic Predictors Of Adverse Outcomes In Primary Pulmonary Hypertension.
|
| ECLA GIK
|
Estudios Cardiologicos Latinoamerica Glucose-Insulin-Potassium Pilot Trial
|
| ECLIPSE
|
Ensure's Vascular Closure Device Speeds Hemostasis Trial
|
| ECRIS
|
Endocoronary-Rhenium-Irradiation-Study
|
| ECSG-1
|
European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator
|
| ECSG-6
|
European Cooperative Study Group For Recombinant Tissue-Type Plasminogen Activator II
|
| ECSS
|
European Coronary Surgery Study Group
|
| ECST
|
European Carotid Surgery Trial
|
| EDGECAP
|
Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Community-Acquired Pneumonia
|
| EDGESST
|
Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Skin And Soft Tissue Infections
|
| EDGE
|
Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities
|
| EDGEUTI
|
Evaluation Of Daptomycin (Cidecin) In Gram-Positive Entities In The Treatment Of Complicated Urinary Tract Infection
|
| ED-IMPACT
|
Emergency Department Impedance Cardiography-Aided Assessment Changes Therapy Sponsor: Cardiodynamics International
|
| EFICAT
|
Ejection Fraction In Cardiac Transplant Patients
|
| EGASIS
|
Early Gaba-Ergic Activation Sin Troke
|
| ELATE
|
Extended Low-Intensity Anticoagulation For Thrombo-Embolism Investigators
|
| ELECT
|
Evaluating Enoxaparin (Lovenox) Clotting Times
|
| ELITE
|
Evaluation Of Losartan In The Elderly
|
| ELITE-II
|
Losartan Heart Failure Survival Study
|
| ELLDOPA
|
Earlier Versus Later Levodopa In Parkinson Disease
|
| ELUTES
|
European Evaluation Of Paclitaxel Eluting Stent
|
| ELVD-CHF
|
Exercise In Left Ventricular Dysfunction And Chronic Heart Failure Trial
|
| EMERALD
|
Enhanced Myocardial Efficacy And Removal By Aspiration Of Liberated Debris
|
| EMERALD
|
European And Australian Multicenter Evaluative Research On Atrial Fibrillation—Dofetilide
|
| EMERAS
|
Estudio Multicentrico Estreptoquinasa Republicas De America Del Sur
|
| EMIAT
|
European Myocardial Infarction Amiodarone Trial
|
| EMIP
|
Prehospital Thrombolytic Therapy In Patients With Suspected Acute Myocardial Infarction
|
| EMIP-FR
|
European Myocardial Infarction Project—Free Radicals
|
| EMIT
|
European Mivazerol Trial
|
| EMPIRIC
|
Comparison Of Empiric To Physician-Tailored Programming Of Implantable Cardioverter Defibrillators Trial
|
| ENABLE
|
Effects Of The Endothelin Receptor Antagonist Bosentan On The Morbidity And Mortality In Patients With Chronic Heart Failure
|
| ENCOR
|
Enrasentan Cooperative Randomized Evaluation
|
| ENCORE I
|
Evaluation Of Nifedipine And Cerivastatin On Recovery Of Coronary Endothelial Function
|
| ENCORE II
|
Long-Term Effect Of Nifedipine On Vasomotion And Vessel Morphology In Patients With Coronary Artery Disease: An Intravascular Ultrasound-Assisted Evaluation
|
| ENDEAVOR II
|
Randomized Comparison Of The Endeavor Abt-578 Drug Eluting Stent With A Bare Metal Stent For Coronary Revascularization
|
| ENDEAVOR III
|
Randomized Comparison Of Zotarolimus-Eluting And Sirolimus-Eluting Stents In Patients With Coronary Artery Disease-3
|
| ENDEAVOR IV
|
Randomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease-4
|
| ENDEAVOR-1
|
Multicenter Evaluation Of Abt-578 Elution From A Phosphorylcholine-Coated Stent
|
| ENHANCE
|
Simvastatin With Or Without Ezetimibe In Familial Hypercholesterolemia
|
| ENRICHD
|
Enhancing Recovery In Coronary Heart Disease
|
| ENTIRE
|
Enoxaparin And Tnk-Tpa With Or Without Gp IIb/IIia Inhibitor As Reperfusion Strategy In St Elevation Mi (TIMI-23)
|
| EPAMSA
|
Estudio Piloto Argentino De Muerte Subita Y Amioda Rone (Argentine Pilot Study Of Sudden Death And Amiodarone)
|
| EPAT
|
Estrogen In The Prevention Of Atherosclerosis Trial
|
| EPHESUS
|
Eplerenone Post-Ami Heart Failure Efficacy And Survival Study
|
| EPIC
|
Evaluation Of C7E3 For The Prevention Of Ischemic Complications
|
| EPILOG
|
Evaluation Of Ptca To Improve Long-Term Outcome By C7E3 Gp IIb/IIia Receptor (Abciximab) Blockade
|
| EPISTENT
|
Evaluation Of Platelet IIb/IIia Inhibitor For Stenting Trial
|
| EPOS
|
Elective Pci In Outpatient Study
|
| ERA
|
Enoxaparin Restenosis (Era) Trial.
|
| ERA
|
Early Rheumatoid Arthritis (Ra) Enoxaparin Restenosis After Angioplasty StudyEstrogen Replacement And Atherosclerosis Study
|
| ERA (HRT)
|
Effect Of Estrogen Replacement On The Progression Of Coronary Artery Atherosclerosis
|
| ERACI
|
Estudio Randomizado Argentino De Angioplastia Vs. Cirugía (Argentine Randomized Trial Of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery In Multivessel Disease)
|
| ERACI II
|
Argentine Randomized Study: Coronary Angioplasty With Stenting Vs. Coronary Artery Bypass Surgery In Patients With Multiple-Vessel Disease (Eraci II): 30-Day And One Year Follow-Up Results
|
| ERASE
|
Emergency Room Assessment Of Sestamibi For Evaluation Of Chest Pain
|
| ERASE
|
Effects Of Rhdl On Atherosclerosis–Safety And Efficacy
|
| ERASER
|
Evaluation Of Reopro And Stenting To Eliminate Restenosis
|
| ERBAC
|
Excimer Laser, Rotational Atherectomy, Balloon Angioplasty Complications Study
|
| ERGO
|
Etomoxir For The Recovery Of Glucose Oxidation
|
| ERICA
|
Efficacy Of Ranolazine In Chronic Angina
|
| ERNA
|
Early Return To Normal Activities At Two Weeks After Acute Myocardial Infarction: Preliminary Results Of A Randomized Study
|
| ER-TIMI
|
Early Retavase - Thrombolysis In Myocardial Infarction
|
| ESCAMI
|
Evaluation Of The Safety And Cardioprotective Effects Of Eniporide In Acute Myocardial Infarction
|
| ESCAPE
|
Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness
|
| ESCAPE
|
Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness
|
| E-SIRIUS
|
European Sirolimus-Eluting Stent In Coronary Lesions
|
| ESPRIT
|
Enhanced Suppression Of The Platelet IIb/IIia Receptor With Integrilin TherapyEuropean Study Of The Prevention Of Reocclusion After Initial ThrombolysisEvaluation Of Subcutaneous Proleukin In A Randomized International Trial
|
| ESPRIT HRT
|
Oestrogen In The Prevention Of Reinfarction Trial
|
| ESPS2
|
European Stroke Prevention Study 2
|
| ESPS-2
|
European Stroke Prevention Study 2
|
| ESSENCE
|
Efficacy And Safety Of Subcutaneous Enoxaparin In Unstable Angina And Non-Q-Wave Mi
|
| ESSENCE
|
Efficacy And Safety Of Subcutaneous Enoxaparin In Non–Q-Wave Coronary Events
|
| ESSENTIAL
|
The Studies Of Oral Enoximone Therapy In Advanced Heart Failure
|
| ESSENTIAL
|
The Studies Of Oral Enoximone Therapy In Advanced Heart Failure
|
| ESTAT
|
European Stroke Treatment With Ancrod Trial
|
| ESTEEM
|
Efficacy And Safety Of The Oral Direct Thrombin Inhibitor Ximelagatran In Patients After Acute Myocardial Infarction
|
| ESVEM
|
Electrophysiologic Study Versus Electrocardiographic Monitoring Trial
|
| ETHECC
|
Evaluation Of Thymitaq In Hepatocellular Carcinoma
|
| ETICA
|
Exercise Training Intervention After Coronary Angioplasty: The Etica Trial
|
| ETROP
|
Early Treatment Of Retinopathy Of Prematurity
|
| EURIDIS and ADONIS
|
Maintenance Of Sinus Rhythm With Dronedarone In Patients With Atrial Fibrillation Or Flutter
|
| EUROACTION
|
Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme
|
| EUROCARE
|
Carvedilol For Prevention Of Restenosis After Directional Coronary Atherectomy
|
| EUROPA
|
European Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease
|
| EURO-SPAH
|
European Sonotherapy Trial To Prevent Arterial Hyperplasia
|
| Euro-SPAH
|
European-Sonotherapy Prevention Of Arterial Hyperplasia
|
| EUROSTAR
|
European Cobalt Stent With Antiproliferative For Restenosis Trial
|
| EUTOPIA
|
European Trial On Olmesartan And Pravastatin In Inflammation And Atherosclerosis
|
| EVA
|
Common Carotid Intima-Media Thickness Predicts Occurrence Of Carotid Atherosclerotic Plaques: Longitudinal Results From The Aging Vascular Study
|
| EVA-AMI
|
Eptifibatide Versus Abciximab In Primary Pci For Acute St Elevation Myocardial Infarction
|
| EVEREST
|
Efficacy Of Vasopressin Antagonism In Heart Failure: Outcome Study With Tolvaptan
|
| EVEREST I
|
Endovascular Valve Edge-To-Edge Repair Study
|
| EVET
|
Enoxaparin Versus Tinzaparin In Non-St-Segment Elevation Acute Coronary Syndromes
|
| EVIDENCE
|
Evidence For Interferon Dose-Effect: European-North American Comparative Efficacy Study (Rebif V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms))
|
| EVIDENT
|
Endo-Vascular Investigation Determining The Safety Of A New Tacrolimus Eluting Stent Graft
|
| EVIDENT
|
Endovascular Investigation Determining The Safety Of A New Tacrolimus-Eluting Stent Graft
|
| EXCITE
|
Evaluation Of Oral Xemilofiban In Controlling Thrombotic Events
|
| EXCITE
|
Evaluation Of Oral Xemilofiban In Controlling Thrombotic Events
|
| EXCITe
|
Extremity Constraint-Induced Therapy
|
| EXCLAIM
|
Extended Clinical Prophylaxis In Acutely Ill Medical Patients (Lovenox (Enoxaparin) Postmarketing (Phase Iv) Trial)
|
| EXPEDITION
|
Na+/H+ Exchange Inhibition To Prevent Coronary Events In Acute Cardiac Conditions
|
| EXPIRA
|
Thrombectomy With Export Catheter In Infarct-Related Artery During Primary Percutaneous Coronary Intervention
|
| ExTRACT
|
Enoxaparin And Thrombolysis Reperfusion For Acute Myocardial Infarction Treatment
|
| F.I.R.E.
|
Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial
|
| FAAT
|
Fatty Acid Antiarrhythmia Trial
|
| FACET
|
Flosequinan - Ace Inhibition Trial
|
| FACET
|
Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial
|
| FACIT
|
Folate After Coronary Intervention Trial
|
| FACT
|
Effect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty
|
| FAME
|
Fractional Flow Reserve Versus Angiography For Multivessel Evaluation
|
| FAME
|
Fluvastatin (Lescol) Assessment Of Morbi-Mortality In The Elderly
|
| FAMIS
|
Fosinopril In Acute Myocardial Infarction Study
|
| FANTASTIC
|
Randomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting
|
| FAST
|
Femoral Artery Stenting Trial
|
| FASTER
|
Fibrinolytic And Aggrastat St Elevation Resolution First Abarelix Depot Study For Treating Endometriosis RapidlyFirst And Second Trimester Evaluation Of Risk
|
| FAST-MAG
|
Field Administration Of Stroke Therapy - Magnesium
|
| FATS
|
Familial Atherosclerosis Treatment Study
|
| FEMINA
|
Addition Of Felodipine To Metoprolol Vs. Replacement Of Metoprolol By Felodipine In Patients With Angina Pectoris Despite Adequate Beta-Blockade
|
| FERRIC-HF
|
Effect Of Intravenous Ferrous Sucrose On Exercise Capacity In Chronic Heart Failure
|
| FEST
|
Fosinopril Efficacy/Safety Trial
|
| FIELD
|
Fenofibrate Intervention And Event Lowering In Diabetes
|
| FIELD
|
Fenofibrate (Tricor) Intervention And Event Lowering In Diabetes
|
| FINESSE
|
Facilitated Intervention With Enhanced Reperfusion Speed To Stop Events
|
| FIRE
|
Filterwire Ex Randomized Evaluation
|
| FIRST
|
Flolan International Randomized Survival Trial (Phase IIi (Develop Economic Data))
|
| FIRST
|
Flolan (Dobutamine) International Randomized Survival Trial First Trimester Integrated Risk Screening For Trisomy
|
| FLARE
|
Fluvastatin Angioplasty Restenosis
|
| FLARE
|
Fluvastatin (Lescol) Angiographic Restenosis
|
| FLORIDA
|
Fluvastatin On Risk Diminishing After Acute Myocardial Infarction
|
| FLUCAD
|
Influenza Vaccination In Secondary Prevention From Coronary Ischemic Events In Coronary Artery Disease
|
| FOOD
|
Feed Or Ordinary Diet
|
| FOSIT
|
Fosamax International Trial
|
| FRAXIS
|
Fraxiparin Versus Unfractionated Heparin In The Treatment Of Unstable Angina
|
| FRAXIS / FRAX.I.S.
|
Fraxiparine In Ischemic Syndromes
|
| FRESCO
|
Investigators In The Florence Randomized Elective Stenting In Acute Coronary Occlusions
|
| FRIC
|
Fragmin In Unstable Coronary Artery Disease
|
| FRIC
|
Fragmin In Unstable Coronary Artery Disease
|
| FRISC
|
Fast Revascularization During Instability In Coronary Artery Disease
|
| FRISC II
|
Fragmin And Fast Revascularization During Instability In Coronary Artery Disease
|
| FROST
|
French Optimal Stenting Trial
|
| FROSTY
|
Freezor Trial Of Supraventricular Tachycardia
|
| FTT
|
Fibrinolytic Therapy Trialists' Collaborative Group
|
| FUSION
|
Fractional Flow Reserve And Ultrasound Indices For Objective Narrowing Assessment
|
| FUSION I
|
Follow-Up Serial Infusions Of Nesiritide Trial
|
| FUTURE I
|
First Use To Underscore Restenosis Reduction With Everolimus
|
| FUTURE II
|
Multicenter Evaluation Of The Biosbsorbable Polymer-Based Everolimus-Eluting Stent
|
| GABI
|
German Angioplasty Vs. Bypass Surgery Investigation
|
| GABI-2
|
German Angioplasty Bypass Investigation - 2
|
| GAMI
|
Glucose Abnormalities In Patients With Myocardial Infarction: Prevalence, Diagnosis, And Prognostic Implications
|
| GAMMA II
|
Gamma II Localized Radiation Therapy To Inhibit Restenosis
|
| GAMMA V
|
Gamma V Localized Radiation Therapy To Inhibit Restenosis
|
| Gamma-One
|
Localized Intracoronary Gamma-Radiation Therapy To Inhibit The Recurrence Of Restenosis After Stenting
|
| GART study
|
Genotypic Antiretroviral Resistance Testing
|
| GEMICA
|
Morbidity And Mortality Following Early Administration Of Amiodarone In Myocardial Infarction
|
| GEMINI
|
Glycemic Effects In Diabetes Mellitus: Carvedilol - Metoprolol Comparison In Hypertensives Trial
|
| GEMS
|
'Ginkgo Biloba 'Evaluation Memory Study
|
| GENESIS
|
A Randomized, Multicenter Study Of The Pimecrolimus-Eluting And Pimecrolimus/Paclitaxel-Eluting Coronary Stent System In Patients With De Novo Lesions Of The Native Coronary Arteries
|
| GENEVA
|
Intracoronary Beta Irradiation To Reduce Restenosis After Balloon Angioplasty
|
| GENIUS-STEMI
|
A Randomized Comparison Of Genous Stent Versus Chromium-Cobalt Stent For Treatment Of St-Elevation Myocardial Infarction
|
| GenSalt
|
Genetic Epidemiology Network Of Salt Sensitivity
|
| GESICA
|
Randomized Trial Of Low-Dose Amiodarone In Severe Congestive Heart Failure
|
| GIPS
|
Randomized Trial Of Glucose-Insulin-Potassium Infusion On 30 Day Mortality In Patients With Acute Myocardial Infarction Treated With Primary Angioplasty
|
| GIPS II
|
Glucose - Insulin - Potassium Study In Patients With St Elevation Myocardial Infarction Without Signs Of Heart Failure
|
| GISEN
|
Gruppo Italiano Di Studi Epidemiologici In Nefrologia
|
| GISSI-1
|
Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-1
|
| GISSI-2
|
Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico Acuto-2
|
| GISSI-3
|
Effects Of Lisinopril And Transdermal Glycerol Trinitrate Singly And Together On 6-Week Mortality And Ventricular Function After Ami
|
| GISSI-HF: n-3 PUFA
|
Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: N-3 Pufa
|
| GISSI-HF: Rosuvastatin
|
Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell’Infarto Miocardico–Heart Failure: Rosuvastatin
|
| GOSPEL
|
Global Secondary Prevention Strategies To Limit Event Recurrence After Myocardial Infarction
|
| G-PAD
|
Granulocyte-Macrophage Colony Stimulating Factor In Patients With Intermittent Claudication
|
| GRACIA I
|
Randomized Trial Comparing Stenting Within 24 Hours Of Thrombolysis Versus Ischemia-Guided Approach To Thrombolysed Acute Myocardial Infarction With St Elevation
|
| GRACIA II
|
Primary Optimal Percutaneous Coronary Intervention Versus Facilitated Intervention In Stemi Patients
|
| GRAPE
|
Grampian Region Early Anistreplase Trial
|
| GUARDIAN
|
Inhibition Of The Sodium-Hydrogen Exchanger With Cariporide To Prevent Myocardial Infarction In High-Risk Ischemic Situations: Main Results Of The Guard During Ischemia Against Necrosis (Guardian) Trial
|
| GUSTO
|
Global Utilization Of Streptokinase And Tpa For Occluded Arteries
|
| GUSTO IIB
|
Global Utilization Of Streptokinase And Tpa For Occluded Arteries IIb
|
| GUSTO V
|
The Gusto V Randomised Trial
|
| GUSTO-3
|
Global Utilization Of Streptokinase And Tpa For Occluded Arteries-III
|
| GUSTO-SPEED
|
Global Utilization Of Streptokinase And Tpa For Occluded Arteries–Strategies For Patency Enhancement In The Emergency Department
|
| HAAMU-STENT
|
Helsinki Area Acute Myocardial Infarction Treatment Re-Evaluation - Should The Patients Get A Drug-Eluting Or Normal Stent
|
| HACA
|
Mild Therapeuric Hypothermia To Improve The Neurologic Outcome After Cardiac Arrest
|
| HAEST
|
Heparin In Acute Embolic Stroke Trial
|
| HALT-C
|
Hepatitis C Antiviral Long-Term Treatment To Prevent Cirrhosis
|
| HALT-MI
|
Hu23F2G Anti-Adhesion To Limit Cytotoxic Injury Following Ami
|
| HANDLS
|
Health Aging In Nationally Diverse Longitudinal Samples
|
| HANE
|
Randomized, Double-Blind Multicenter Comparison Of Hydrochlorothiazide, Atenolol, Nitrendipine, And Enalapril In Antihypertensive Treatment
|
| HARDBALL
|
Heart Allograft Rejection: Detection With Breath Alkanes In Low Level
|
| HARDBALL
|
Heart Allograft Rejection: Detection With Breath Alkanes In Low Levels
|
| HARP
|
Harvard Atherosclerosis Reversibility Project
|
| HART
|
Heparin-Aspirin Reperfusion Trial
|
| HART II
|
Randomized Comparison Of Enoxaparin, A Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive To Recombinant Tissue Plasminogen Activator Thrombolysis And Aspirin: Second Trial Of Heparin And Aspirin Reperfusion Therapy
|
| HAT
|
Home Automatic External Defibrillator Trial
|
| HAT 1
|
Heparin-Associated Thrombocytopenia 1
|
| HAT 2
|
Heparin-Associated Thrombocytopenia 2
|
| HATS
|
Hdl-Atherosclerosis Treatment Study
|
| HDFP
|
Hypertension Detection And Follow-Up Program
|
| HDOM
|
Heart Disease On The Mend
|
| HeADDFIRST
|
Hemicraniectomy And Durotomy For Deterioration From Infarction Relating Swelling Trial
|
| HEART
|
Healing And Early Afterload Reducing Therapy Trial
|
| HEART
|
Healing And Early Afterload Reducing Therapy
|
| HEAT 2
|
Hypertension Endothelin Antagonist Treatment
|
| Heidelberg
|
Heidelberg Trial
|
| HELAS
|
Antithrombotic Therapy In Heart Failure: A Randomized Comparison Of Warfarin Vs. Aspirin
|
| HELAS
|
Antithrombotic Therapy In Heart Failure: A Randomized Comparison Of Warfarin Vs. Aspirin
|
| Helsinki Heart Study
|
Helsinski Heart Study
|
| Helsinki Heart Study
|
Helsinski Heart Study
|
| HEME
|
Hemorrhage Early Mri Evaluation
|
| HERO
|
Hirulog Early Reperfusion/Occlusion Trial
|
| HERO
|
Hirulog Early Reperfusion/Occlusion Trial
|
| HERO-2
|
Hirulog And Early Reperfusion Or Occlusion Trial
|
| HERS
|
Heart And Estrogen/Progestin Replacement Study
|
| HERS
|
Heart And Estrogen/Progestin Replacement Study Hiv Epidemiology Research Study
|
| HESTIA
|
Home Evaluation Of Stroke Induced Aid
|
| HF-ACTION
|
Heart Failure–A Randomized Controlled Trial Investigating Outcomes Of Exercise Training
|
| HF-ACTION Substudy
|
Effect Of Exercise Training On Health-Related Quality Of Life In Patients With Chronic Heart Failure
|
| HHH
|
Home Or Hospital Heart Failure
|
| HIJ-CREATE
|
Heart Institute Of Japan Candesartan Randomized Trial For Evaluation In Coronary Artery Disease
|
| HIPS
|
Heparin Infusion Prior To Stenting
|
| HIT
|
Hdl-Cholesterol Intervention Trial Hirudin For The Improvement Of Thrombolysis
|
| HIT-I
|
Hirudin For The Improvement Of Thrombolysis
|
| HIT-III
|
Hirudin For Improvement Of Thrombolysis
|
| HOME
|
Hyperinsulinemia: The Outcome Of Its Metabolic Effects
|
| HOPE
|
Heart Outcomes Prevention Evaluation
|
| HOPE
|
The Heart Outcomes Prevention Evaluation Study
|
| HOPE-2
|
Heart Outcomes Prevention Evaluation
|
| HOPE-TOO
|
Heart Outcomes Prevention Evaluation - The Ongoing Outcomes
|
| HORIZON
|
Health Outcomes And Reduced Incidence With Zoledronic Once Yearly
|
| HORIZONS-AMI
|
Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
|
| HORIZONS-AMI Stent
|
Harmonizing Outcomes With Revascularization And Stents In Acute Myocardial Infarction
|
| HOS
|
Hypertension-Obesity-Sibutramine
|
| HOT
|
Hypertension Optimal Treatment Study
|
| HOT
|
Hypertension Optimum Treatment
|
| HPS
|
Medical Research Council/British Heart Foundation Heart Protection Study
|
| HPS
|
Heart Protection Study
|
| HRS
|
Health And Retirement Study
|
| Hy-C
|
The Hydralazine Captopril Trial
|
| HYVET
|
Hypertension In The Very Elderly Trial
|
| HYVET
|
Hypertension In The Very Elderly Trial
|
| IBIS-2
|
Integrated Biomarker And Imaging Study-2
|
| ICE-IT
|
Intravascular Cooling Adjunctive To Primary Coronary Intervention
|
| ICON
|
Ionic Versus Nonionic Contrast To Obviate Worsening Nephropathy After Angioplasty In Chronic Renal Failure Patients
|
| ICSS
|
International Carotid Stenting Study (Cavatas-2)
|
| ICTUS
|
Invasive Versus Conservative Treatment In Unstable Coronary Syndromes
|
| IDEAL
|
Incremental Decrease In Clinical Endpoints Through Aggressive Lipid Lowering
|
| IDEAL
|
Incremental Decrease In Endpoints Through Aggressive Lipid Lowering Iressa Dose Evaluation In Advanced Lung Cancer
|
| IDNT
|
Irbesartan Diabetic Nephropathy Trial
|
| IDNT
|
Irbesartan In Diabetic Nephropathy Trial
|
| IHAST
|
Intraoperative Hypothermia For Aneurysm Surgery Trial
|
| ILLUMINATE
|
Investigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events
|
| ILLUSTRATE
|
Investigation Of Lipid Level Management Using Coronary Ultrasound To Assess Reduction Of Atherosclerosis By Cetp Inhibition And Hdl Elevation
|
| IMAGES
|
Intravenous Magnesium Efficacy In Stroke
|
| IMAGINE
|
Ischemia Management With Accupril Post-Bypass Graft Via Inhibition Of The Converting Enzyme
|
| IMAGINE
|
Ischemic Management With Accupril Post Bypass Graft Via Inhibition Of Converting Enzyme
|
| IMPACT
|
Integrilin To Manage Platelet Aggregation To Prevent Coronary Thrombosis International Mexiletine Or Placebo Antiarrhythmic Coronary TrialInternational Multiple Sclerosis Secondary Progressive Avonex Controlled Trial
|
| IMPACT II
|
Integrilin To Minimise Platelet Aggregation And Coronary Thrombus - II
|
| IMPACT-HF
|
Initiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure
|
| IMPRESS
|
Immunosuppressive Therapy For The Prevention Of Restenosis After Coronary Artery Stent Implantation
|
| IMPRESS
|
Inhibition Of Metalloprotease By Bms-186716 In A Randomized Exercise And Symptoms Study
|
| IMPROVE-CHF
|
Improved Management Of Patients With Congestive Heart Failure
|
| IMS
|
Interventional Management Of Stroke Study
|
| IN-CHF
|
Italian Network - Congestive Heart Failure
|
| INCOMIN
|
Independent Comparison Of Interferon (Betaseron V. Avonex In Relapsing-Remitting Multiple Sclerosis (Rrms)
|
| InDDEx
|
Investigation Into Delay To Diagnosis Of Alzheimer Disease With Exelon
|
| INHIBIT
|
Intimal Hyperplasia Inhibition With Beta In-Stent Trial
|
| INHIBIT
|
Intimal Hyperplasia Inhibition With Beta In-Stent Trial
|
| INJECT
|
International Joint Efficacy Comparison Of Thrombolytics
|
| INSIGHT
|
International Nifedipine Gits Study: Intervention As A Goal In Hypertension Treatment
|
| INSIGHT
|
International Nifedipine Once-Daily Study – Intervention As A Goal In Hypertension Treatment
|
| INSPIRE
|
Adenosine Sestamibi Post-Infarction Evaluation (Inspire) Trial
|
| INSYNC
|
Multisite Pacing As A Supplemental Treatment Of Congestive Heart Failure: The Medtronic Inc. Insync Study
|
| INTACT
|
Iressa Non–Small Cell Lung Cancer Trial Assessing Combination Treatment
|
| INTAMI
|
Integrilin In Acute Myocardial Infarction
|
| INTEGRITI
|
Integrilin And Tenecteplase In Acute Myocardial Infarction
|
| INTEGRITI
|
Integrilin And Tenecteplase In Acute Myocardial Infarction
|
| INTERACT
|
Integrilin And Enoxaparin Randomized Assessment Of Acute Coronary Syndrome Treatment
|
| INTERCEPT
|
Incomplete Infarction Trial Of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (Diltiazem)
|
| INTERHEART
|
A Study Of Risk Factors For First Myocardial Infarction In 52 Countries And Over 27,000 Subjects
|
| InTIME
|
Intravenous Npa For Treatment Of Infarcting Myocardium Early
|
| InTime-2
|
Intravenous Npa For Treatment Of Infarcting Myocardium Early
|
| INTrEPID
|
Investigation Of Non–Transplant-Eligible Patients Who Are Inotrope Dependent See
|
| INTRINSIC RV
|
Inhibition Of Unnecessary Rv Pacing With Av Search Hysteresis In Icds
|
| INTRO-AMI
|
Integrilin And Reduced Dose Of Thrombolytic In Acute Myocardial Infarction
|
| INVEST
|
International Verapamil-Trandolapril Study
|
| IONA
|
Effect Of Nicorandil On Coronary Events In Patients With Stable
|
| IONA
|
Impact Of Nicorandil In Angina
|
| IONDT
|
Ischemic Optic Neuropathy Decompression Trial
|
| I-PRESERVE
|
Rbesartan In Heart Failure With Preserved Ejection Fraction Study
|
| IRAS
|
Insulin Resistance Atherosclerosis Study
|
| IRIS
|
Isostent For Restenosis Intervention Study
|
| IRIS
|
Isostent For Restenosis Intervention Study
|
| IRMA 2
|
Irbesartan In Type 2 Diabetes With Microalbuminuria 2
|
| IRMA 2
|
Irbesartan (Avapro) Microalbuminuria Type 2
|
| ISAAC
|
International Study Of Asthma And Allergies In Childhood
|
| ISAM
|
Intravenous Streptokinase In Acute Myocardial Infarction
|
| ISAR
|
Intracoronary Stenting And Antithrombotic Regimen Trial
|
| ISAR
|
Individualizable Drug-Eluting Stent System To Abrogate Restenosis Project
|
| ISAR
|
Intracoronary Stenting And Antithrombotic Regimen
|
| ISAR DIABETES
|
Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent For The Prevention Of Restenosis In Diabetic Patients With Coronary Artery Disease
|
| ISAR REACT
|
Intracoronary Stenting And Antithrombotic Regimen Rapid Early Action For Coronary Treatment
|
| ISAR-CHOICE
|
Intracoronary Stenting And Antithrombotic Regimen: Choose Between 3 High Oral Doses For Immediate Clopidogrel Effect
|
| ISAR-COOL
|
Intracoronary Stenting With Antithrombotic Regimen Cooling-Off
|
| ISAR-DESIRE
|
Drug-Eluting Stents For In-Stent Restenosis
|
| ISAR-LEFT MAIN
|
Intracoronary Stenting And Angiographic Results: Drug-Eluting Stents For Unprotected Coronary Left Main Lesions
|
| ISAR-PEACE
|
Intracoronary Stenting And Angiographic Restenosis: Promote Endothelial Cells With Estradiol
|
| ISAR-REACT 2
|
Intracoronary Stenting And Antithrombotic Regimen: Rapid Early Action For Coronary Treatment
|
| ISAR-REACT 3
|
Bivalirudin Versus Unfractionated Heparin During Percutaneous Coronary Intervention
|
| ISAR-SHOCK
|
Impella Lp2.5 Vs. Iabp In Cardiogenic Shock
|
| ISAR-STEREO
|
Intracoronary Stenting And Angiographic Results: Strut Thickness Effect On Restenosis Outcomes (Isar-Stereo) Trial
|
| ISAR-STEREO
|
Intracoronary Stenting And Angiographic Results - Strut Thickness Effect On Restenosis Outcome
|
| ISAR-STEREO - 2
|
Intracoronary Stenting And Angiographic Results - Strut Thicness Effect On Restenosis Outcome Trial - 2
|
| ISAR-SWEET
|
Is Abciximab A Superior Way To Eliminate Elevated Thrombotic Risk In Diabetics
|
| ISAR-TEST
|
Randomized Trial Of The Yukon Nonpolymer-Based Rapamycin-Coated Stent And The Polymer-Based Paclitaxel-Eluting Stent In Patients With Coronary Artery Disease
|
| ISAR-TEST-2
|
Intracoronary Stenting And Angiographic Results–Test Efficacy Of 3 Limus-Eluting Stents
|
| ISAR-TEST-3
|
Intracoronary Stenting And Angiographic Restenosis Investigators – Test Efficacy Of Rapamycin-Eluting Stents With Different Polymer Coating Strategies
|
| ISAT
|
International Subarachnoid Aneurysm Trial
|
| ISIS-1
|
First International Study Of Infarct Survival
|
| ISIS-2
|
International Study Of Infarct Survival-2
|
| ISIS-3
|
International Study Of Infarct Survival-3
|
| ISIS-4
|
Fourth International Study Of Infarct Survival
|
| IST
|
The International Stroke Trial
|
| ISTICH
|
International Surgical Trial In Intracerebral Hemorrhage
|
| ITALICS
|
Investigation By The Thoraxcenter On Antisense Dna Using Local Delivery And Ivus After Coronary Stenting
|
| ITT
|
Intraventricular Thrombolysis Trial
|
| IVAT
|
Intermediate Sized Vessel Atherectomy Trial
|
| JAMIS
|
Effects Of Aspirin And Trapidil On Cardiovascular Events After Acute Myocardial Infarction
|
| JELIS
|
Japan Epa Lipid Intervention Study
|
| JPAD
|
Japanese Primary Prevention Of Atherosclerosis With Aspirin For Diabetes
|
| JSAP
|
Japanese Stable Angina Pectoris Study
|
| JUMBO-TIMI 26
|
Joint Utilisation Of Medications To Block Platelets Optimally
|
| JUPITER
|
Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin
|
| J-WIND
|
Japan Working Groups Of Acute Myocardial Infarction For The Reduction Of Necrotic Damage By Atrial Natriuretic Peptide Or Nicorandil
|
| KAT II
|
Kuopio Angiogenesis Trial
|
| LACI
|
Laser Angioplasty For Critical Ischemia
|
| LADIP
|
Loire-Ardèche-Drôme-Isère-Puy-De-Dôme
|
| LAMP
|
Locally Advanced Multimodality Protoco
|
| LARS
|
Laser Angioplasty In Restenosed Stents
|
| LATE
|
Late Assessment Of Thrombolytic Efficacy Study
|
| LAVA
|
Prospective, Randomized, Multicenter Comparison Of Laser-Facilitated Balloon Angioplasty Versus Stand-Alone Balloon Angioplasty In Patients With Obstructive Coronary Artery Disease
|
| L-CAD
|
Lipid-Coronary Artery Disease (Pravastatin)
|
| LCAS
|
The Lipoprotein And Coronary Atherosclerosis Study (Lcas): Lipid And Metabolic Factors Related To Atheroma And Clinical Events
|
| LEADER
|
Lower Extremity Arterial Disease Event Reduction Trial
|
| LEADERS
|
Limus Eluted From A Durable Vs Erodable Stent Coating
|
| LHT
|
Lifestyle Heart Trial
|
| LIDO
|
Levosimendan Infusion Versus Dobutamine
|
| LIFE
|
Losartan Intervention For Endpoint Reduction In Hypertension (Life) Study
|
| LIMB
|
Limbs International Medical Buflomedil Trial
|
| LIMIT AMI
|
Limitation Of Myocardial Infarction Following Thrombolysis In Acute
|
| LIMIT-2
|
Second Leicester Magnesium Intervention Trial
|
| LIPID
|
Long-Term Intervention With Pravastatin In Ischemic Disease Trial
|
| LIPS
|
Lescol Intervention Prevention Study
|
| LISA
|
Lescol In Severe Atherosclerosis Trial
|
| LOCAT
|
Prevention Of The Angiographic Progression Of Coronary And Vein-Graft Atherosclerosis By Gemfibrozil After Coronary Bypass Surgery In Men With Low Levels Of Hdl Cholesterol
|
| LONG DES II
|
Randomized Comparison Of The Efficacy Of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent In The Treatment Of Long Native Coronary Lesions
|
| LONG-DES
|
Multicenter Prospective Nonrandomized Registry Study For Drug-Eluting Stents In Very Long Coronary Lesions (Cypher Vs Taxus)
|
| LRC-CPPT
|
Lipid Research Clinics Coronary Primary Prevention Trial
|
| MACH-1
|
Mortality Assessment In Congestive Heart Failure Trial
|
| MADIT
|
Multicenter Automatic Defibrillator Implantation Trial
|
| MADIT-II
|
Multicenter Automatic Defibrillator Implantation Trial II
|
| MAGIC
|
Magnesium In Coronaries
|
| MAGIC
|
Myoblast Autologous Grafting In Ischemic Cardiomyopathy
|
| MAGIC – Presented at AHA 2006
|
Myoblast Autologous Grafting In Ischemic Cardiomyopathy
|
| Male Health
|
Male Health Professionals Study
|
| MAPPET-3
|
Management Strategies And Prognosis Of Pulmonary Embolism-3 Trial
|
| MARS
|
The Monitored Atherosclerosis Regression Study
|
| MASCOT
|
Management Of Atrial Fibrillation Suppression In Af-Hf Comorbidity Therapy
|
| MASS
|
The Medicine, Angioplasty Or Surgery Study
|
| MASS
|
The Multicenter Aneurysm Screening Study (Mass) Into The Effect Of Abdominal Aortic Aneurysm Screening On Mortality In Men: A Randomized Controlled Trial
|
| MASS-II
|
Second Medicine, Angioplasty, Or Surgery Study
|
| MAST-E
|
Thrombolytic Therapy With Streptokinase In Acute Ischemic Stroke
|
| MASTER
|
Microvolt T Wave Alternans Testing For Risk Stratification Of Post-Myocardial Infarction Patients
|
| MATCH
|
Management Of Atherothrombosis With Clopidogrel In High-Risk Patients
|
| MATE
|
Medicine Versus Angiography In Thrombolytic Exclusion Trial
|
| MATH
|
Endocrine And Renal Effects Of Nifedipine Gastrointestinal Theraputic System In Patients With Essential Hypertension: Results Of A Multicenter Trial
|
| Matisse
|
Subcutaneous Fondaparinux Versus Intravenous Unfractionated Heparin In The Initial Treatment Of Pulmonary Embolism
|
| MATTIS
|
Randomized Evaluation Of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation In High-Risk Patients: The Multicenter Aspirin And Ticlopidine Trial After Intracoronary Stenting
|
| MAVErIC II
|
30-Day Results From A Prospective Registry Of Carotid Stenting With The Exponent Stent And Distal Protection With The Guardwire In High Risk Patients
|
| MaVS
|
Metoprolol After Vascular Surgery
|
| MDC
|
Metoprolol In Dilated Cardiomyopathy Trial
|
| MDPIT
|
The Multicenter Diltiazem Post Infarction Trial
|
| MDRD
|
Modification Of Diet In Renal Disease Study
|
| MEDAL Program
|
Multinational Etoricoxib And Diclofenac Arthritis Long-Term Study Program
|
| MEDENOX
|
Prophylaxis In Medical Patients With Enoxaparin
|
| MEGA
|
Management Of Elevated Cholesterol In The Primary Prevention Group Of Adult Japanese
|
| MEND-CABG II
|
Mc-1 To Eliminate Necrosis And Damage In Coronary Artery Bypass Graft Surgery II — Presented At Scai-Acc I2 Summit/Acc 2008
|
| MERIT-HF
|
Metoprolol Cr/Xl Randomized Intervention Trial In Congestive Heart Failure
|
| MERLIN
|
Middlesbrough Early Revascularization To Limit Infarction
|
| MERLIN-TIMI 36
|
Metabolic Efficiency With Ranolazine For Less Ischemia In Nste-Acs
|
| METAFER
|
Use Of Metoprolol To Maintain Sinus Rhythm After Conversion From Persistent Atrial Fibrillation
|
| METEOR
|
Measuring Effects On Intima-Media Thickness: An Evaluation Of Rosuvastatin
|
| MEXIS
|
The Effects Of B-Receptor Antagonists In Patients With Clinical Evidence Of Heart Failure After Myocardial Infarction: Double Blind Comparison Of Meto
|
| M-HART
|
Montreal Heart Attack Readjustment Trial
|
| MHFT
|
Munich Mild Heart Failure Trial
|
| MIAMI
|
Metoprolol In Acute Myocardial Infarction
|
| MICRO-HOPE
|
Microalbuminuria, Cardiovascular, And Renal Outcomes - Heart Outcomes Prevention Evaluation
|
| MILIS
|
Multiple Center Investigation Of The Limit Of Infarction
|
| MINT
|
A Multicenter, Randomized Study Of Argatroban Versus Heparin As Adjunct To Tissue Plasminogen Activator (Tpa) In Acute Myocardial Infarction: Myocardial Infarction With Novastan And Tpa (Mint) Study
|
| MIRACL
|
Effects Of Atorvastatin On Early Recurrent Ischemic Events In Acute Coronary Syndromes. The Miracl Study: A Randomized Controlled Trial
|
| MIRACLE ICD
|
Multicenter Insync Implantable Cardioversion Defibrillation Randomized Clinical Evaluation
|
| MIST
|
Migraine Intervention With Starflex Technology
|
| MITI I
|
Myocardial Infarction Triage And Intervention Project--Phase I
|
| MITI II
|
Myocardial Infarction Triage And Intervention Project--Phase I
|
| MITRA
|
Maximal Individual Therapy In Acute Myocardial Infarction
|
| MOMENTUM
|
Multicenter Trial Of The Orqis Medical Cancion System For The Enhanced Treatment Of Heart Failure Unresponsive To Medical Therapy
|
| MONICA
|
Monitoring Trends And Determinants In Cardiovascular Disease
|
| MOST
|
Mode Selection Trial (Most) In Sinus Node Dysfunction
|
| MOXCON
|
Excess Mortality In Chf Patients Treated With Sr Moxonidine Leads To Study Termination: Results Of The Sr Moxonidine For Congestive Heart Failure Trial
|
| M-PATHY
|
Multicenter Pacing Therapy
|
| MPIP
|
Multicenter Post-Infarction Program
|
| MR PCI
|
Multicenter Registry Of High-Risk Percutaneous Coronary Intervention And Adequate Platelet Inhibition
|
| MRFIT
|
Multiple Risk Factor Intervention Trial
|
| MUSIC
|
Multicenter Ultrasound Guided Stent Implantation In The Coronaries
|
| MUST-EECP
|
Multicenter Enhanced External Counterpulsation
|
| MUSTIC
|
Multisite Stimulation In Cardiomyopathies Study
|
| MUSTT
|
Multicenter Unsustained Tachycardia Trial
|
| MVP
|
Multivitamins And Probucol Study
|
| NAMIS
|
Nifedipine Angina Myocardial Infarction Study
|
| NAPA
|
Nesiritide Administered Peri-Anesthesia In Patients Undergoing Cardiac Surgery
|
| NAPLES II
|
Novel Approaches For Preventing Or Limiting Events II
|
| NASCET
|
North American Symptomatic Carotid Endarterectomy Trial
|
| NEPHRIC
|
Nephrotoxicity In High-Risk Patients Study Of Isoosmolar And Low-Osmolar Non-Ionic Contrast Media Study
|
| NETWORK
|
Clinical Outcome With Enalapril In Symptomatic Chronic Heart Failure: A Dose Comparison
|
| NHANES III
|
Third National Health And Nutrition Examination Survey
|
| NHLBI
|
The National Heart, Lung And Blood Institute Type II Coronary Intervention Study
|
| NHLBI Dynamic
|
Nhlbi Dynamic Registry Of Percutaneous Interventions: A Comparison To The 1985-86 Registry
|
| NICE
|
Nitrates In Congestive Heart Failure (Nice) Study
|
| NICE-SUGAR
|
Normoglycemia In Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation
|
| NICOLE
|
Nisoldipine For Coronary Artery Disease In Leuven
|
| NICS-EH
|
National Intervention Cooperative Study In Elderly Hypertensives
|
| NO-PAIN
|
Nitric Oxide In Peripheral Arterial Insufficiency
|
| NORDIL
|
Nordic Diltiazem Study
|
| NORVIT
|
Norwegian Vitamin Trial
|
| Norwegian Nifedipine
|
Norwegian Nifedipine Multi-Center Trial
|
| NRMI-2
|
National Registry Of Myocardial Infarction (Second Phase)
|
| NUT-2
|
Efficacy Assessment Of Meloxicam, A Preferential Cyclooxygenase-2 Inhibitor, In Acute Coronary Syndromes Without St-Segment Elevation. The Nonsteroidal Anti-Inflammatory Drugs In Unstable Angina Treatment-2 (Nut-2) Pilot Study
|
| OARS
|
Optimal Atherectomy Restenosis Study
|
| OASIS-1
|
Organization To Assess Strategies For Ischemic Syndromes
|
| OASIS-2
|
Effects Of Long-Term, Moderate-Intensity Oral Anticoagulation In Addition To Aspirin In Unstable Angina
|
| OASIS-6
|
Organization For The Assessment Of Strategies For Ischemic Syndromes 6
|
| OASIS-6 – GIK
|
Oasis-6 – Glucose-Insulin-Potassium
|
| OAT
|
Occluded Artery Trial
|
| OCBAS
|
Optimal Coronary Balloon Angioplasty With Provisional Stenting Vs. Stent Trial
|
| OCLA
|
Omeprazole Clopidogrel Aspirin
|
| ODESSA
|
Optical Coherence Tomography For Des Safety
|
| ODIXa-DVT
|
Oral Direct Factor Xa Inhibitor Bay 59-7939 In Patients With Acute Symptomatic Deep-Vein Thrombosis
|
| ODIXa-HIP
|
Oral, Direct Factor Xa Inhibitor, Bay 59-7939, Given Once Daily In Patients Undergoing Total Hip Replacement
|
| OMEGA
|
Randomized Trial Of Omega-3 Fatty Acids On Top Of Modern Therapy After Acute Myocardial Infarction
|
| ONTARGET
|
Ongoing Telmisartan Alone And In Combination With Ramipril Global Endpoint Trial
|
| ON-TIME
|
Ongoing Tirofiban In Myocardial Infarction Evaluation Trial
|
| On-TIME 2
|
Ongoing Tirofiban In Myocardial Infarction Evaluation 2 Trial
|
| OPALS
|
Ontario Prehospital Advanced Life Support
|
| OPT-CHF
|
Oxypurinol Compared With Placebo For Class III-Iv Nyha Congestive Heart Failure
|
| OPTIC
|
Optimal Pharmacological Therapy In Cardioverter Defibrillator Patients Trial
|
| OPTIMAAL
|
Effects Of Losartan And Captopril On Mortality And Morbidity In High-Risk Patients After Acute Myocardial Infarction
|
| OPTIME-CHF
|
Outcomes Of A Prospective Trial Of Intravenous Milrinone For Exacerbations Of Chronic Heart Failure
|
| OPTIMIZE
|
Effect Of Image Optimization With Contrast On The Diagnostic Accuracy Of Dobutamine Echocardiography In Coronary Artery Disease
|
| OPUS
|
Optimal Angioplasty Versus Primary Stenting
|
| ORAR II
|
Oral Treatment Of Restenosis
|
| ORBIT
|
Oral Glycoprotein IIb/IIia Receptor Blockade To Inhibit Thrombosis
|
| OSIRIS
|
Oral Sirolimus To Inhibit Recurrent In-Stent Stenosis
|
| OVERTURE
|
Omapatrilat Versus Enalapril Randomized Trial Of Utility In Reducing Events
|
| PABA CHF
|
Pulmonary Vein Antrum Isolation Vs. Av Node Ablation With Biventricular Pacing For Treatment Of Atrial Fibrillation In Patients With Congestive Heart Failure
|
| PACCOCATH ISR
|
Treatment Of In-Stent Restenosis By Paclitaxel Coated Ptca Balloons
|
| PACE
|
Prevention By Low Dose Aspirin Of Cardiovascular Disease In The Elderly
|
| PACIFIC
|
Percutaneous Transmyocardial Laser Revascularization For Severe Angina: The Pacific Randomized Trial
|
| PACT
|
Plasminogen Activator-Angioplasty Compatibility Trial
|
| PACT (Pravastatin)
|
Pravastatin In Acute Coronary Treatment
|
| PAD
|
Public Access Defibrillation Trial
|
| PAMI
|
The Primary Angioplasty In Myocardial Infarction Study
|
| PAMI-stent
|
The Primary Angioplasty In Myocardial Infarction Study
|
| PAPABEAR
|
Prophylactic Amiodarone For The Prevention Of Arrhythmias That Begin Early After Revascularization, Valvular Repair Or Replacement
|
| PARAGON
|
Delaying And Preventing Ischemic Events In Patient With Acute Coronary Syndromes Using The Platelet Gp IIb/IIia Inhibitor Lamifiban
|
| PARAGON B
|
Platelet IIb/IIia Antagonist For The Reduction Of Acute Coronary Syndrome Events In A Global Organization Network
|
| PARIS
|
Effect Of Ace Inhibitors On Angiographic Restenosis After Coronary Stenting (Paris): A Randomised, Double-Blind, Placebo-Controlled Trial
|
| PASE
|
Pacemaker Selection In The Elderly
|
| PASE(QOL)
|
Quality Of Life And Clinical Outcomes In Elderly Patients Treated With Ventricular Pacing As Compared With Dual-Chamber Pacing
|
| PASSION
|
Paclitaxel Eluting Stent Versus Conventional Stent In St-Segment Elevation Myocardial Infarction
|
| PATAF
|
Primary Prevention Of Arterial Thromboembolism In Non-Rheumatic Atrial Fibrillation In Primary Care: Randomised Controlled Trial Comparing Two Intensities Of Coumarin With Aspirin
|
| PATCH
|
Program To Assess Alternative Treatment Strategies To Achieve Cardiac Health
|
| PATH-CHF
|
The Pacing Therapies For Congestive Heart Failure (Path-Chf) Study
|
| PAVE
|
Biventricular Pacing After Ablate Compared With Right Ventricular Therapy
|
| PCI CLARITY
|
Clopidogrel As Adjunctive Reperfusion Therapy: Percutaneous Coronary Intervention Subgroup Study
|
| PCI-CURE
|
Effects Of Pretreatment With Clopidogrel And Aspirin Followed By Long-Term Therapy In Patients Undergoing Percutaneous Coronary Intervention: The Pci-Cure Study
|
| PCI-ExTRACT-TIMI 25
|
Percutaneous Coronary Intervention Among Patients Treated With Enoxaparin Versus Unfractionated Heparin Following Fibrinolytic Administration For St-Elevation Mi
|
| PC-Trial
|
Physical Counterpressure Manoeuvre Trial
|
| PEACE
|
Platelet Activity Extinction In Non–Q-Wave Myocardial Infarction With Aspirin, Clopidogrel, And Eptifibatide
|
| PEACE
|
Prevention Of Events With Angiotensin-Converting Enzyme Inhibition Trial
|
| PEECH
|
Prospective Evaluation Of Enhanced External Counterpulsation In Congestive Heart Failure
|
| PENTUA
|
Pentasaccharide In Unstable Angina
|
| PEP
|
Pulmonary Embolism Prevention Trial
|
| PEPAF
|
Experimental Program For Physical Activity Promotion
|
| PEP-CHF
|
Perindopril For Elderly People With Chronic Heart Failure
|
| PEPI
|
Postmenopausal Estrogen/Progestin Interventions
|
| PERISCOPE
|
Pioglitazone Effect On Regression Of Intravascular Sonographic Coronary Obstruction Prospective Evaluation
|
| PERM
|
Prospective Evaluation Of Reperfusion Markers
|
| PERSUADE
|
Perindopril Substudy In Coronary Artery Disease And Diabetes: The Diabetic Substudy Of Europa
|
| Perth
|
Perth Community Stroke Study
|
| PERTINENT
|
Perindopril, Thrombosis, Inflammation, Endothelial Dysfunction, And Neurohormonal Activation Trial, A Subanalysis Of Europa
|
| PHS II
|
Physicians' Health Study II
|
| PIAF
|
Rhythm Or Rate Control In Atrial Fibrillation-Pharmacological Intervention In Atrial Fibrillation (Piaf): A Randomised Trial
|
| PICTURE
|
Post-Intracoronary Treatment Ultrasound Result Evaluation
|
| PIHRATE
|
Polish-Italian-Hungarian Randomized Thrombectomy Trial
|
| PIONEER
|
Proactive, Prospective Pioglitazone Clinical Trial In Macrovascular Events
|
| PIOPED
|
Prospective Investigation Of Pulmonary Embolism Diagnosis Study
|
| PLAC-II
|
Pravastatin, Lipids, And Atherosclerosis In The Carotid Arteries II
|
| PLASMA
|
Phospholipase Levels And Serological Markers Of Atherosclerosis
|
| POISE
|
Perioperative Ischemic Evaluation
|
| POSCH
|
Program On The Surgical Control Of The Hyperlipidemias
|
| POST
|
Prevention Of Syncope Trial
|
| Post CABG
|
Post Coronary Artery Bypass Graft Trial
|
| POZNAN
|
Percutaneous Transvenous Transplantation Of Autologous Myoblasts In The Treatment Of Postinfarction Heart Failure
|
| PPAR Study
|
Peroxisome Proliferator–Activated Receptor Study
|
| PPP
|
Primary Prevention Project
|
| PQRST
|
Probucol Quantitative Regression Swedish Trial
|
| PRACTICAL
|
Comparison Of Enalapril Versus Captopril On Left Ventricular Function And Survival Three Months After Acute Myocardial Infarction
|
| PRAGUE
|
Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis
|
| PRAGUE-8
|
Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis-8
|
| PRAISE
|
Prospective Randomized Amlopidine Survival Evaluation
|
| PRAISE-1
|
Prospective Randomized Amlodipine Survival Evaluation-1
|
| PRAISE-2
|
Prospective Randomized Amlodipine Survival Evaluation-2
|
| PREAMI
|
Perindopril Remodeling In Elderly With Acute Myocardial Infarction
|
| PRECISE
|
Double-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
|
| PREDICT
|
Effect Of Pravastatin On Angiographic Restenosis After Coronary Balloon Angioplasty
|
| PREMIAR
|
Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
|
| PREMIER
|
Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
|
| PREPAIR
|
Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional Regimens
|
| PREPARE — Presented at TCT 2008
|
Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation
|
| PREPIC
|
A Clinical Trial Of Vena Caval Filters In The Prevention Of Pulmonary Embolism In Patients With Proximal Deep-Vein Thrombosis
|
| Pre-RELAX-AHF
|
Preliminary Study Of Relaxin In Acute Heart Failure
|
| PRESENT
|
Preliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
|
| PRESERVE
|
Prospective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
|
| PRESTO
|
Results Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
|
| PREVEND IT
|
Prevention Of Renal And Vascular End-Stage Disease Intervention Trial
|
| PREVENT
|
Prospective Randomized Evaluation Of The Vascular Effects Of Norvasc Trial
|
| PREVENT (Dalteparin)
|
Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
|
| PREVENT (Warfarin)
|
Prevention Of Recurrent Venous Thromboembolism
|
| PREVENT II
|
The Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg
|
| PREVENT IV
|
Project Of Ex-Vivo Vein Graft Engineering Via Transfection
|
| PREVENT(Radiation)
|
Proliferation Reduction With Vascular Energy Trial
|
| PRIDE
|
A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
|
| PRIMA — Presented at ACC.09/i2
|
Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
|
| PRIME-2
|
Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
|
| PRIMI
|
Pro-Urokinase For Myocardial Infarction
|
| PRIMO-CABG
|
Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
|
| PRIMO-CABG II
|
Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
|
| PRINCE
|
Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
|
| PRINCESS
|
Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
|
| PRINCIPLE-TIMI 44
|
The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
|
| PRISM
|
Platelet-Receptor Inhibition For Ischemic Syndrome Management
|
| PRISM-PLUS
|
Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
|
| PRISM-Troponin
|
Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
|
| PRISON II
|
Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
|
| PROactive
|
Prospective Pioglitazone Clinical Trial In Macrovascular Events
|
| PROCAM
|
Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
|
| PRoFESS
|
Prevention Regimen For Effectively Avoiding Second Strokes
|
| PROFILE
|
Prospective Randomized Flosequinan Longevity Evaluation
|
| PROGRESS
|
Perindopril Protection Against Recurrent Stroke Study
|
| PROGRESS-1
|
Coronary Stenting With Absorbable Metal Stents
|
| PROMISE
|
Protection Devices In Pci-Treatment Of Myocardial Infarction For Salvage Of Endangered Myocardium Study
|
| PROMISE
|
The Effects Of Oral Milrinone On Mortality In Severe Chronic Heart Failure
|
| PROSPER
|
Prospective Study Of Pravastatin In The Elderly At Risk
|
| PROTECT - TIMI 30
|
Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents
|
| PROTECT AF
|
Randomized Prospective Trial Of Percutaneous Left Atrial Appendage Closure Versus Warfarin For Stroke Prevention In Atrial Fibrillation
|
| PROTECT-CAD
|
Prospective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases
|
| PROVE IT/TIMI 22
|
Pravastatin Or Atorvastatin Evaluation And Infection Therapy: Thrombolysis In Myocardial Infarction 22
|
| PROVE IT-TIMI 22 (Gatifloxacin)
|
Pravastatin Or Atorvastatin Evaluation And Infection Therapy
|
| PROVED
|
Randomized Study Assessing The Effect Of Digoxin Withdrawal In Patients With Mild To Moderate Chronic Congestive Heart Failure: Results Of The Proved
|
| PROVIDENCE 1
|
Prospective Evaluation Of Rifalazil Effect On Vascular Symptoms Of Intermittent Claudication And Other Endpoints In Chlamydia Seropositive Patients
|
| PROXIMAL
|
Proximal Protection During Saphenous Vein Graft Intervention
|
| PURSUIT
|
Platelet Glycoprotein IIb/IIia In Unstable Angina:Receptor Suppression Using Integrilin Therapy
|
| QUASAR
|
Quinapril Anti-Ischemia And Symptoms Of Angina Reduction
|
| QUIET
|
Quinapril Ischemic Event Trial
|
| R3
|
Reopro Readministration Registry
|
| RAAMI
|
Randomized Angiographic Trial Of Recombinant Tissue-Type Plasminogen Activator (Alteplase) In Myocardial Infarction
|
| RABBIT II
|
Randomized Angioplasty Beta Blocker Intracoronary Trial II
|
| RACE
|
Rate Control Versus Electrical Cardioversion For Persistent Atrial Fibrillation
|
| RACS
|
Randomized Argentine Clopidogrel Stent Trial
|
| RACTS
|
A Prospective, Randomized Multicenter Trial Of Cilostozal Vs Ticlopidine In Patients Undergoing Stent Implantation
|
| RADIANCE
|
Withdrawal Of Digoxin From Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibitors
|
| RADIANCE 1
|
Rating Atherosclerotic Disease Change By Imaging With A New Cetp Inhibitor
|
| RADIANCE 2
|
Rating Atherosclerotic Disease Change By Imaging With A New Cetp Inhibitor - 2
|
| RALES
|
Randomized Aldactone Evaluation Study
|
| RaMI
|
Prehospital Thrombolysis In Rural Emergency Room And Subsequent Transport To A Coronary Care Unit: Ravenna Myocardial Infarction (Rami) Trial
|
| RAPID-1
|
Recombinant Plasminogen Activator Angiographic Phase II International Dose-Finding Study
|
| RAPID-2
|
Reteplase Vs Alteplase Patency Investigation During Myocardial Infarction
|
| RAPPORT
|
Reopro And Primary Ptca Organization And Randomized Trial
|
| RAPS
|
Radial Artery Patency Study
|
| RAPT
|
Ridogrel Versus Aspirin Patency Trial
|
| RAVE
|
Regional Angiogenesis With Vascular Endothelial Growth Factor In Peripheral Arterial Disease
|
| RAVEL
|
A Randomized Comparison Of A Sirolimus-Eluting Stent With A Standard Stent For Coronary Revascularization
|
| REACH
|
Reinforcing Education About Cholesterol
|
| REACH Registry
|
Reduction Of Atherothrombosis For Continued Health Registry
|
| REACT
|
Rescue Angioplasty Versus Conservative Therapy Or Repeat Thrombolysis Trial
|
| REACT
|
Rapid Early Action For Coronary Treatment
|
| REALITY
|
Prospective Randomized Multi-Center Head-To-Head Comparison Of The Sirolimus-Eluting Stent (Cypher) And The Paclitaxel-Eluting Stent (Taxus
|
| RECORD
|
Rosiglitazone Evaluated For Cardiovascular Outcomes — An Interim Analysis
|
| RECORD1
|
Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 1
|
| RECORD2
|
Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 2
|
| RECORD3
|
Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 3
|
| RECOVER
|
Renal Toxicity Evaluation And Comparison Between Visipaque And Hexabrix In Patients With Renal Insufficiency Undergoing Coronary Angiography
|
| RECOVERS
|
Randomized Evaluation Of Polytetrafluoroethylene-Covered Stent In Saphenous Vein Grafts
|
| REDHOT
|
Rapid Emergency Department Heart Failure Outpatient Trial
|
| RED-LIP
|
Trial Of Pravastatin In Primary Isolated Hypercholesterolemia
|
| REDUCE
|
Low Molecular Weight Heparin (Reviparin) In Percutaneous Transluminal Coronary Angioplasty
|
| REDUCE III
|
A Prospective, Randomized Multicenter Trial Of Cutting Balloon Before Stenting In Patients Undergoing Pci
|
| REFLECT
|
Double-Blind, Placebo-Controlled Study Of The Efficacy Of Flosequinan In Patients With Chronic Heart Failure
|
| REGENT
|
Myocardial Regeneration By Intracoronary Infusion Of Selected Population Of Stem Cells In Acute Myocardial Infarction
|
| REGICOR
|
Improvement In Survival After Myocardial Infarction Between 1978-85 And 1986-88 In The Regicor Study
|
| REGRESS
|
Effects Of Lipid Lowering By Pravastatin On Progression And Regression Of Coronary Artery Disease In Symptomatic Men With Normal To Moderately Elevated Serum Cholesterol Levels. The Regression Growth Evaluation Statin Study (Regress)
|
| RELAx-AMI
|
Randomized Early Versus Late Abciximab In Acute Myocardial Infarction Treated With Primary Coronary Intervention
|
| RELOAD
|
Reload With Clopidogrel Before Coronary Angioplasty In Subjects Treated Long Term With Dual Antiplatelet Therapy
|
| REMATCH
|
Randomized Evaluation Of Mechanical Assistance For The Treatment Of Congestive Heart Failure
|
| REMEDIA
|
Randomized Evaluation Of The Effect Of Mechanical Reduction Of Distal Embolization By Thrombus-Aspiration In Primary And Rescue Angioplasty
|
| REMEDIAL
|
Renal Insufficiency Following Contrast Media Administration Trial
|
| RENAAL
|
Effects Of Losartan On Renal And Cardiovascular Outcomes In Patients With Type 2 Diabetes And Nephropathy
|
| RENEWAL - RECOVER
|
Research Into Etanercept Cytokine Antagonism In Ventricular Dysfunction
|
| RENEWAL - RENAISSANCE
|
Randomized Etanercept North American Strategy To Study Antagonism Of Cytokines
|
| REPAIR-AMI
|
Reinfusion Of Enriched Progenitor Cells And Infarct Remodeling In Acute Myocardial Infarction
|
| REPLACE 2
|
Randomized Evaluation Of Pci Linking Angiomax To Reduced Clinical Events
|
| RESCUE
|
Randomized Evaluation Of Salvage Angioplasty With Combined Utilization Of Endpoints
|
| RESEARCH
|
Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital Registry
|
| RESIST
|
Impact Of Intravascular Ultrasound Guidance In Stent Deployment On 6-Month Restenosis Rate: A Multicenter, Randomized Study Comparing Two Strategies--With And Without Intravascular Ultrasound Guidance
|
| RESOLVD
|
Randomized Evaluation Of Strategies For Left Ventricular Dysfunction Pilot
|
| REST
|
Restenosis Stent Trial
|
| Restenosis Stent
|
Coronary-Artery Stenting Compared With Balloon Angioplasty For Restenosis After Initial Balloon Angioplasty
|
| RESTORE
|
Randomized Efficacy Study Of Tirofiban For Outcome And Restenosis
|
| RethinQ
|
Resynchronization Therapy In Patients With Narrow Qrs
|
| REVERSAL
|
Reversing Atherosclerosis With Aggressive Lipid Lowering
|
| REVERSE
|
Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction
|
| REVERT
|
Reversal Of Ventricular Remodeling With Toprol-Xl
|
| REVIVAL-3
|
The Regeneration Of Vital Myocardium In St-Segment Elevation Myocardial Infarction By Erythropoietin
|
| RHYTHM II ICD
|
Resynchronization For The Hemodynamic Treatment For Heart Failure Management II Implantable Cardioverter Defibrillator
|
| RIO-Europe
|
A Randomized Double-Blind Study Of Weight Reducing Effect And Safety Of Rimonabant In Obese Patients With Or Without Comorbidities
|
| RIO-Lipids
|
Rimonabant In Obesity
|
| RIO-NA
|
Rimonabant On Weight Reduction And Weight Maintenance: Rio-North America
|
| RIS
|
Efficacy Of Multiple Risk Factor Intervention In Treated Hypertensive Men
|
| RISC
|
Research On Instability In Coronary Artery Disease
|
| RITA
|
Randomized Intervention Treatment Of Angina Trial
|
| RITA II
|
The Second Randomized Intervention Treatment Of Angina
|
| RITA-3
|
Randomized Trial Of A Conservative Treatment Strategy Versus An Interventional Treatment Strategy In Patients With Unstable Angina
|
| RITZ 2
|
Randomized Intravenous Tezosentan For The Treatment Of Acute Heart Failure
|
| RITZ-4
|
Randomized Intravenous Tezosentan Study
|
| RIVIERA Registry
|
Registry On Intra-Venous Anticoagulation In The Elective And Primary Real World Of Angioplasty
|
| ROADMAP
|
Randomized Olmesartan And Diabetes Microalbuminuria Prevention Trial
|
| ROBUST
|
Recanalization Of Chronically Occluded Aorto-Coronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion Of Urokinase Trial
|
| ROMAS
|
Romanian Multicenter Study - Accelerated Streptokinase In Acute Myocardial Infarction
|
| ROSTER
|
Randomized Trial Of Rotational Atherectomy Versus Balloon Angioplasty For Diffuse In-Stent Restenosis
|
| ROXIS
|
Roxithromycin In Non-Q Wave Coronary Syndromes
|
| RSVP
|
Radial Artery Versus Saphenous Vein Patency
|
| RUSSLAN
|
Safety And Efficacy Of A Novel Calcium Sensitizer, Levosimendan, In Patients With Left Ventricular Failure Due To An Acute Myocardial Infarction
|
| RUTH
|
Raloxifene Use For The Heart
|
| SADHART
|
Sertraline Treatment Of Major Depression In Patients With Acute Mi Or Unstable Angina
|
| SAFE
|
Safety After Fifty Evaluation
|
| SAFER
|
The Saphenous Vein Graft Angioplasty Free Of Emboli Randomized Trial
|
| SAFE-T
|
Sotalol Amiodarone Atrial Fibrillation Efficacy Trial
|
| SAGE
|
Study Assessing Goals In The Elderly
|
| SALT
|
Swedish Aspirin Low-Dose Trial
|
| SALT 1 and 2
|
Study Of Ascending Levels Of Tolvaptan In Hyponatremia
|
| SALTIRE
|
Scottish Aortic Stenosis And Lipid Lowering Trial
|
| SANDS
|
Stop Atherosclerosis In Native Diabetics Study
|
| SAPAT
|
Double-Blind Trial Of Aspirin In Primary Prevention Of Myocardial Infarction In Patients With Stable Chronic Angina Pectoris
|
| SAPPHIRE
|
Stenting And Angioplasty With Protection In Patients At High Risk For Endarterectomy
|
| SARECCO
|
Stent Or Angioplasty After Recanalization Of Chronic Coronary Occlusions Trial
|
| SAVE
|
Survival And Ventricular Enlargement Trial
|
| SAVE PACe
|
Search Av Extension And Managed Ventricular Pacing For Promoting Atrioventricular Conduction
|
| SAVED
|
Saphenous Vein De Novo
|
| SCANDSTENT
|
Stenting Of Coronary Arteries In Non Stress/Benestent Disease Trial
|
| SCAT
|
Long-Term Effects Of Cholesterol Lowering And Angiotension-Converting Enzyme Inhibition On Coronary Atherosclerosis. The Simvastatin/Enalapril Coronary Atherosclerosis Trial (Scat).
|
| SCD-HeFT
|
Sudden Cardiac Death In Heart Failure Trial
|
| SCOR
|
University Of California, San Francisco, Arteriosclerosis Specialized Center Of Research (Scor) Intervention Trial
|
| SCORE
|
Study To Compare Restenosis Rate Between Quest And Quadds-Qp2
|
| SCRIP
|
Study Of Cardiovascular Risk Intervention By Pharmacists
|
| SCRIPPS
|
Scripps Coronary Radiation To Inhibit Proliferation Post Stenting
|
| SCRIPPS II
|
Scripps Coronary Radiation To Inhibit Proliferation Post Stenting II
|
| SCRIPPS III
|
Scripps Coronary Radiation To Inhibit Proliferation Post Stenting III
|
| SCRIPPS IV
|
Scripps Coronary Radiation To Inhibit Proliferation Post Stenting Iv
|
| SEARCH
|
Study Of The Effectiveness Of Additional Reductions In Cholesterol And Homocysteine
|
| SEAS
|
Simvastatin And Ezetimibe In Aortic Stenosis
|
| SECURE
|
Study To Evaluate Carotid Ultrasound Changes In Patients Treated With Ramipril And Vitamin E
|
| SEEDS
|
Syncope Evaluation In The Emergency Department Study
|
| SEISMIC
|
Safety And Effects Of Implanted (Autologous) Skeletal Myoblasts (Myocell) Using An Injection Catheter
|
| SENIOR PAMI
|
Senior Primary Angioplasty In Myocardial Infarction Study
|
| SENIORS
|
Study Of Effects Of Nebivolol Intervention On Outcomes And Rehospitalisation In Seniors With Heart Failure
|
| SESAIR
|
Randomised Comparison Of Subcutaneous Heparin, Intravenous Heparin, And Aspirin In Unstable Angina
|
| SESAMI
|
Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction
|
| SES-SMART
|
Sirolimus-Eluting Stent And A Standard Stent In The Prevention Of Restenosis In Small Coronary Arteries
|
| SHARP
|
The Subcutaneous Heparin And Angioplasty Restenosis Prevention (Sharp) Trial. Results Of A Multicentre Randomized Trial Investigating The Effects Of High Dose Unfractionated Heparin On Angiographic Restenosis And Clinical Outcome
|
| SHEP
|
Systolic Hypertension In Elderly Program
|
| SHIELD
|
Shock Inhibition Evaluation With Azimilide
|
| SHOCK
|
Should We Emergently Revascularize Occluded Coronaries For Cardiogenic Shock?
|
| SIAM
|
Comparison Of Invasive And Conservative Strategies After Treatment With Streptokinase In Acute Myocardial Infarction
|
| SIAM III
|
Southwest German Interventional Study In Acute Myocardial Infarction
|
| SICCO
|
Stenting In Chronic Coronary Occlusion
|
| SIMPADICO
|
Study Of Immune Modulation Therapy In Patients With Symptomatic Peripheral Arterial Disease
|
| SIPS
|
Ultrasound-Guided Stratification For Provisional Stenting With Focal Balloon Combination Catheter. Results From The Randomized Strategy For Intracoronary Ultrasound-Guided Ptca And Stenting (Sips) Trial
|
| SIRIUS
|
Sirolimus-Eluting Stent In Coronary Lesions
|
| SIRIUS-2
|
Safety And Efficacy Of An Intravenous Placebo-Controlled Randomized Infusion Of Ularitide
|
| SIRTAX
|
Sirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization
|
| SISR
|
Sirolimus-Eluting Stent Vs. Brachytherapy In Patients With Bare Metal In-Stent Restenosis
|
| SLIP
|
Lipid Profile During Antihypertensive Treatment
|
| SMART
|
Surgical Management Of Arterial Revascularization Therapies
|
| SMART
|
Sirolimus-Eluting Stents For The Treatment Of Obstructive Superficial Femoral Artery Disease
|
| SMARTT
|
A Randomized Trial Of The Effects Of Early Cardiac Serum Marker Availability On Reperfusion Therapy In Patients With Acute Myocardial Infarction. The Serial Markers, Acute Myocardial Infarction And Rapid Treatment Trial (Smartt)
|
| SMASH-VT
|
Substrate Mapping And Ablation In Sinus Rhythm To Halt Ventricular Tachycardia
|
| SMILE
|
The Effects Of The Angiotensin-Converting-Enzyme Inhibitor Zofenopril On Mortality And Morbidity After Anterior Myocardial Infarction
|
| SMT
|
Stockholm Metoprolol Trial
|
| SOFA
|
Study On Omega-3 Fatty Acids And Ventricular Arrhythmia
|
| SOLVD-Treatment
|
The Effects Of Enalapril On Survival In Patients With Reduced Left Ventricular Ejection Fractions And Congestive Heart Failure (Treatment Trial)
|
| SORT OUT II
|
Comparison Of Paclitaxel- And Sirolimus-Eluting Stents In Everyday Clinical Practice
|
| SoS
|
Coronary Artery Bypass Surgery Vs. Percutaneous Coronary Intervention With Stent Implantation In Patients With Multivessel Coronary Disease (The Stent Or Surgery Trial)
|
| SPACE
|
Secondary Prevention With Antioxidants Of Cardiovascular Disease In End-Stage Renal Disease (Space): Randomized Placebo-Controlled Trial
|
| SPAF
|
Stroke Prevention In Atrial Fibrillation Study
|
| SPAN CHF
|
Specialized Primary And Networked Care In Heart Failure
|
| SPARCL
|
Stroke Prevention By Aggressive Reduction In Cholesterol Levels
|
| SPIC
|
Long-Term Survival Effect Of Metoprolol In Dilated Cardiomyopathy
|
| SPICE
|
Study Of Patients Intolerant Of Converting Enzyme Inhibitors
|
| SPICE – Presented at ACC 2007
|
Survival And Prognosis: Investigation Of Crataegus Extract Ws 1442 In Chf
|
| SPINAF
|
Stroke Prevention In Nonrheumatic Atrial Fibrillation
|
| SPIRIT
|
A Randomized Trial Of Anticoagulants Versus Aspirin After Cerebral Ischemia Of Presumed Arterial Origin
|
| SPORTIF II
|
Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
|
| SPORTIF III
|
Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
|
| SPORTIF V
|
Stroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
|
| SPRINT
|
Secondary Prevention Reinfarction Israeli Nifedipine Trial
|
| SSSD
|
Spanish Study On Sudden Death
|
| STAF
|
Strategies Of Treatment Of Atrial Fibrillation
|
| STAI
|
Antiplatelet Treatment With Ticlopidine In Unstable Angina (Studio Della Ticlopidine Nell'Angina Instabile)
|
| STAMI
|
Ticlopidine Versus Aspirin After Myocardial Infarction (Stami) Trial
|
| STAMINA
|
Effect Of Treatment For Chlamydia Pneumoniae And Helicobacter Pylori On Markers Of Inflammation And Cardiac Events In Patients With Acute Coronary Syndromes
|
| STAMINA
|
South Thames Trial Of Antibiotics In Myocardial Infarction And Unstable Angina Pectoris
|
| STAR
|
A Randomized Trial Of Recombinant Staphylokinase Versus Altepase For Coronary Artery Patency In Acute Myocardial Infarction
|
| STARC
|
Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study
|
| STARS-Antithrombotic
|
Stent Antithrombotic Regimen Study
|
| STARS-Atherosclerosis
|
St. Thomas Atherosclerosis Regression Study
|
| START
|
Sr90 Treatment Of Angiographic Restenosis
|
| STAT
|
Stenting Vs. Thrombolysis In Acute Myocardial Infarction Trial (Stat)
|
| STEEPLE
|
Safety And Efficacy Of Enoxaparin In Percutaneous Coronary Intervention Patients: An International Randomized Evaluation
|
| STEMMI
|
Stem Cells In Myocardial Infarction
|
| STENT PAMI
|
Stent Primary Angioplasty In Mi
|
| STENTIM-2
|
Immediate Coronary Angioplasty With Elective Wiktor Stent Implantation Compared With Conventional Balloon Angioplasty In Acute Myocardial Infarction
|
| STEP
|
Study Of The Therapeutic Effects Of Intercessory Prayer
|
| STICH
|
Surgical Treatments For Ischemic Heart Failure Hypothesis 2
|
| STIMS
|
Prevention Of Myocardial Infarction And Stroke In Patients With Intermittent Claudication
|
| STING
|
Stents In Grafts
|
| STONE
|
Shanghai Trial Of Nifedipine In The Elderly
|
| STOP-AMI 1
|
Stent Versus Thrombolysis For Occluded Coronary Arteries In Patients With Acute Myocardial Infarction 1
|
| STOP-HTN
|
Swedish Trial In Old Patients With Hypertension
|
| STOP-NIDDM
|
Study To Prevent Noninsulin Dependent Diabetes Mellitus Trial
|
| STRATAS
|
Study To Determine Rotablator And Transluminal Angioplasty Strategy
|
| STRATEGY
|
Single High-Dose Bolus Tirofiban And Sirolimus-Eluting Stent Vs. Abciximab And Bare-Metal Stent In Myocardial Infarction
|
| STRATUS-US
|
Smoking Cessation In Smokers Motivated To Quit
|
| STRESS I
|
Stent Restenosis Study I
|
| SURVIVE
|
Survival Of Patients With Acute Heart Failure In Need Of Intravenous Inotropic Support
|
| SUTAMI
|
Double-Blind Multicenter Comparison Of The Efficacy And Safety Of Saruplase And Urokinase In The Treatment Of Acute Myocardial Infarction: Report Of The Sutami Study Group
|
| SWEDES
|
Swedish Early Decision Trial
|
| SWIFT
|
Should We Intervene Following Thrombolysis?
|
| SWISH
|
Swedish Isradipine Study In Hypertension
|
| SWISSI II
|
Swiss Interventional Study On Silent Ischemia Type II
|
| SWITCH
|
Switching From Lovenox To Angiomax In Patients With Acute Coronary Syndromes Without St Elevation Undergoing Pci
|
| SWORD
|
Survival With Oral D-Sotalol Trial
|
| SYMBIOT III
|
A Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results
|
| SYMPHONY I
|
Sibrafiban Versus Aspirin To Yield Maximum Protection From Ischemic Heart Events Post-Acute Coronary Syndromes
|
| SYMPHONY II
|
Randomized Trial Of Aspirin, Sibrafiban, Or Both For Secondary Prevention After Acute Coronary Syndromes
|
| SYNERGY
|
Superior Yield Of The New Strategy Of Enoxaparin, Revascularization, And Glycoprotein IIb/IIia Inhibitors
|
| SYNERGY-PCI
|
A Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention
|
| SYNTAX
|
Synergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery
|
| Syst-China
|
Systolic Hypertension In China Trial
|
| Syst-Eur
|
For The Syst-Eur Investigators. The Prevention Of Dementia With Antihypertensive Treatment. New Evidence From The Systolic Hypertension In Europe (Syst-Eur) Study
|
| TACT
|
Therapeutic Angiogenesis For Patients With Limb Ischaemia By Autologous Transplantation Of Bone-Marrow Cells:A Pilot Study And A Randomized Controlled Trial.
|
| TACTICS-TIMI 18
|
Treat Angina With Aggrastat And Determine Cost Of Therapy With An Invasive Or Conservative Strategy
|
| TAIM
|
Trial Of Antihypertensive Interventions And Management
|
| TAIST
|
Tinzaparin In Acute Ischaemic Stroke Trial
|
| TALISMAN
|
Therapeutic Angiogenesis With Intramuscular Nv1Fgf In Patients With Critical Limb Ischemia
|
| TAMI-5
|
Thrombolysis And Angioplasty In Myocardial Infarction - Phase V
|
| TAPAS
|
Thrombus Aspiration During Percutaneous Coronary Intervention In Acute Myocardial Infarction
|
| TAPS
|
The Rt-Pa-Apsac Patency Study
|
| TARGET
|
Comparison Of Two Platelet Glycoprotein IIb/IIia Inhibitors, Tirofiban And Abciximab, For The Prevention Of Ischemic Events With Percutaneous Coronary Revascularization
|
| TAUSA
|
Thrombolysis And Angioplasty In Unstable Angina
|
| TAXi
|
Paclitaxel And Sirolimus Stents In The Real World Of Interventional Cardiology
|
| TAXUS III
|
In-Stent Restenosis Treated With Stent-Based Delivery Of Paclitaxel Incorporated In A Slow-Release Polymer Formulation
|
| TAXUS V ISR
|
Paclitaxel-Eluting Stents Vs. Brachytherapy For In-Stent Restenosis
|
| TEAHAT
|
Very Early Thrombolytic Therapy In Suspected Acute Myocardial Infarction
|
| TEAM-2
|
Multicenter Patency Trial Of Intravenous Antistreplase Compared With Streptokinase In Acute Myocardial Infarction
|
| TEAM-3
|
Third Thrombolysis Trial Of Anistreplase (Eminase) In Acute Myocardial Infarction
|
| TEN-HMS
|
Telemonitoring For Heart Failure: Patient Characteristics And First Results
|
| TETAMI
|
Treatment Of Enoxaparin And Tirofiban In Acute Myocardial Infarction
|
| THESEE
|
A Comparison Of Low-Molecular-Weight Heparin With Unfractionated Heparin For Acute Pulmonary Embolism
|
| THINRS
|
The Home Inr Study
|
| THOP
|
Treatment Of Hypertension Based On Home Or Office Blood Pressure
|
| THRIVE
|
Thrombin Inhibitor In Venous Thromboembolism
|
| Thrombectomy in STEMI
|
Thrombectomy In St Elevation Myocardial Infarction
|
| THUNDER
|
Taxan With Short Time For Contact For Reduction Of Restenosis In Distal Arteries
|
| TIBBS
|
Total Ischemic Burden Bisoprolol Study
|
| TIBET
|
Total Ischemic Burden European Trial
|
| TIGER-PA
|
Tirofiban Given In The Emergency Room Before Primary Angioplasty
|
| TIM
|
Triflusal In Myocardial Infarction
|
| TIMACS
|
Timing Of Intervention In Patients With Acute Coronary Syndromes
|
| TIMBER
|
Transthoracic Incremental Monophasic Versus Biphasic Defibrillation By Emergency Responders
|
| TIME
|
Trial Of Invasive Versus Medical Therapy In The Elderly
|
| TIME-CHF
|
Trial Of Intensified Vs Standard Medical Therapy In Elderly Patients With Congestive Heart Failure
|
| TIMI 1
|
Thrombolysis In Myocardial Infarction Trial, Phase I
|
| TIMI 10B
|
Tnk-Tissue Plasminogen Activator Compared With Front-Loaded Tissue Plasminogen Activator In Acute Myocardial Infarction
|
| TIMI 11B
|
Thrombolysis In Myocardial Ischemia Trial, Phase 11B
|
| TIMI 16-OPUS
|
Orbofiban In Patients With Unstable Coronary Syndromes, Thrombolysis In Myocardial Infarction
|
| TIMIC
|
Efficacy Of Immunosuppressive Therapy In Patients With Virus-Negative Inflammatory Cardiomyopathy
|
| TITAN - TIMI 34
|
Time To Integrilin Therapy In Acute Myocardial Infarction
|
| TITAX AMI
|
Titanium Nitride Oxide Coated Stents And Paclitaxel Eluting Stents For Acute Myocardial Infarction
|
| TMLR
|
Transmyocardial Laser Revascularization In Patients With Refractory Angina: A Randomised
|
| TMR
|
Revascularization With Co2 Laser In Patients With Refractory Angina Pectoris: Clinical Results From The Norwegian Randomized Trial
|
| TNT
|
Treating To New Targets Study
|
| TOAT
|
The Occluded Artery Trial
|
| TOHP II
|
Effects Of Weight Loss And Sodium Reduction Intervention On Blood Pressure And Hypertension Incidence In Overweight People With High-Normal Blood Pressure: The Trials Of Hypertension Prevention, Phase II
|
| TOMHS
|
Treatment Of Mild Hypertension Study
|
| TOMIIS
|
Total Occlusion Post-Myocardial Infarction Intervention Study
|
| TONE
|
Sodium Reduction And Weight Loss In The Treatment Of Hypertension In Older Persons: A Randomized Controlled Trial Of Nonpharmacologic Interventions In The Elderly
|
| TOPAS
|
A Comparison Of Recombinant Urokinase With Vascular Surgery As Initial Treatment For Acute Arterial Occlusion Of The Legs
|
| TOSCA
|
Total Occlusion Study Of Canada
|
| TOTAL
|
Total Occlusion Trial With Angioplasty By Using Laser Guidewire
|
| TPT
|
Thrombosis Prevention Trial
|
| TRACE
|
The Trandolapril Cardiac Evaluation Trace Study
|
| TRAFFIC
|
Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 For Intermittent Claudication (The Traffic Study)
|
| TRANSCEND
|
Telmisartan Randomised Assessment Study In Ace Intolerant Subjects With Cardiovascular Disease
|
| TRANSFER-AMI
|
Trial Of Routine Angioplasty And Stenting After Fibrinolysis To Enhance Reperfusion In Acute Myocardial Infarction
|
| TRAPIST
|
Trapidil In Stent
|
| TREND
|
Trial On Reversing Endothelial Dysfunction
|
| TRENDS
|
Tetra Randomized European Direct Stenting Study
|
| TRENT
|
Trial Of Early Nifedipine Treatment In Acute Myocardial Infarction
|
| TRIC
|
Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator During Instability In Coronary Artery Disease: Effect On Myocardial Ischemia And Need For Coronary Revascularization
|
| TRIP-HF
|
Triple Resynchronization In Paced Heart Failure Patients
|
| TRITON-TIMI 38
|
Trial To Assess Improvement In Therapeutic Outcomes By Optimizing Platelet Inhibition With Prasugrel
|
| TRIUMPH
|
Tilarginine Acetate Injection In A Randomized International Study In Unstable Mi Patients With Cardiogenic Shock
|
| TROICA
|
Thrombolysis In Cardiac Arrest
|
| TROPHY
|
Trial Of Preventing Hypertension
|
| TWA in CHF
|
T Wave Alternans In Congestive Heart Failure
|
| TYPHOON
|
Trial To Assess The Use Of The Cypher Stent In Acute Myocardial Infarction Treated With Angioplasty
|
| UKPACE
|
United Kingdom Pacing And Cardiovascular Events
|
| UKPDS
|
United Kingdom Prospective Diabetes Study
|
| UK-TIA
|
The United Kingdom Transient Ischemic Attack Aspirin Trial: Final Results
|
| UNASEM
|
Thrombolysis In Patients With Unstable Angina Improves The Angiographic But Not The Clinical Outcome
|
| UNLOAD
|
Ultrafiltration Versus Intravenous Diuretics For Patients Hospitalized For Acute Decompensated Heart Failure
|
| USIM
|
Urochinasi Per Via Sistemica Nell'Infarto Miocardico
|
| VA-CABG
|
Veterans Affairs (Va) Coronary Artery Bypass Surgery Cooperative Study Group
|
| VADT
|
Veterans Affairs Diabetes Trial
|
| VA-HIT
|
Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial
|
| Val-HeFT
|
Valsartan Heart Failuretrial
|
| VALIANT
|
Valsartan In Acute Myocardial Infarction Trial Investigators
|
| VALIDD
|
Valsartan In Diastolic Dysfunction
|
| VALUE
|
Valsartan Antihypertensive Long-Term Use Evaluation
|
| VANQWISH
|
Veterans Affairs (Va) Non-Q-Wave Infarction Strategies In-Hospital
|
| VASIS
|
Vasovagal Syncope International Study
|
| VASP-02
|
Vasodilator-Stimulated Phosphoprotein-02
|
| VEAPS
|
Vitamin E Atherosclerosis Prevention Study
|
| VEGAS I
|
The Vein Graft Angiojet Study I Pilot Trial
|
| VEGAS-2
|
Vein Graft Angiojet Study 2
|
| VENUS
|
Very Early Nimodipine Use In Stroke
|
| VERBS
|
Ventricular Endocardial Right Bifocal Stimulation In The Treatment Of Severe Dilated Cardiomyopathy Heart Failure With Wide Qrs
|
| VERDICT
|
Verapamil Versus Digoxin And Acute Versus Routine Serial Cardioversion Trial
|
| VERITAS
|
Value Of Endothelin Receptor Inhibition With Tezosentan In Acute Heart Failure Studies
|
| VEST
|
Vesnarinone Survival Trial
|
| VHAS
|
Clinical Results Of The Verapamil In Hypertension And Atherosclerosis Study
|
| VHEFT-I
|
The Effects Of Vasodilator Therapy On Mortality In Chronic Congestive Heart Failure
|
| VHEFT-II
|
Efficacy And Outcome With Felodipine In Heart Failure
|
| VIAMI
|
Viability-Guided Angioplasty After Acute Myocardial Infarction
|
| VICTOR
|
Vioxx In Colorectal Cancer Therapy: Definition Of Optimal Regimen
|
| VINTAGE-MI
|
Vascular Interaction With Age In Myocardial Infarction
|
| VITAL
|
Vasoflux International Trial For Acute Myocardial Infarction Lysis
|
| VIVA
|
Vascular Endothelial Growth Factor In Ischemia For Vascular Angiogenesis
|
| VMAC
|
Vasodilation In The Management Of Acute Congestive Heart Failure
|
| VPS
|
The North American Vasovagal Pacemaker Study
|
| VPS II
|
Vasovagal Pacemaker Study II
|
| WAFACS
|
Women's Antioxidant And Folic Acid Cardiovascular Study
|
| WARIS-II
|
Warfarin, Aspirin, Or Both After Myocardial Infarction
|
| WARSS
|
Warfarin–Aspirin Recurrent Stroke Stud
|
| WATCH
|
Warfarin And Antiplatelet Trial In Chronic Heart Failure
|
| WAVE
|
Warfarin Antiplatelet Vascular Evaluation
|
| WAVE
|
Women's Angiographic Vitamin And Estrogen Trial
|
| WELL-HART
|
Women’s Estrogen–Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial
|
| WENBIT
|
Western Norway B-Vitamin Intervention Trial
|
| WEST
|
Which Early St-Elevation Myocardial Infarction Therapy
|
| WHI
|
Women's Health Initiative
|
| WINS
|
Women's Initiative For Nonsmoking
|
| WISE
|
Women's Ischemia Syndrome Evaluation
|
| WITTI Women
|
Secondary Prevention Beyond Walls Intervention Trial In Women
|
| WIZARD
|
Weekly Intervention With Zithromax For Atherosclerosis And Its Related Disorders
|
| WRIST
|
Washington Radiation For In-Stent Restenosis Trial
|
| ZEST-AMI
|
Zotarolimus-Eluting Stent Vs. Sirolimus-Eluting Stent Vs. Paclitaxel-Eluting Stent For Acute Myocardial Infarction Patients
|